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Giant Viruses are a class of uncommon cellular parasites discovered about 30 years 
ago1. They are defined as Nucleo Cytoplasmic Large DNA viruses (NCLDVs) 
according to the notable viral particle dimensions (about 400nm) and the genome 
complexity. In addition, NCLDVs possess genes with “cell-like properties”, that 
allow the virus to be, at least in part, independent from the host molecular 
mechanisms1. One of the most important pathways that is almost totally encoded 
by NCLDVs is the glycosylation. Generally, viruses use the ER/Golgi compartments 
of the host to glycosylate their own proteins. For NCLDVs, an almost complete 
system to elongate, modify and synthetize the glycoforms is set up in the viral 
factories, which are defined structures in the host cytoplasm.  
The topic of this work was the study and the characterization of two of the six 
putative glycosyltransferases (GTs) from Paramecium bursaria Chlorella virus- 1 
(PBCV-1): A064R and A075L2. PBCV-1 possesses in fact an highly glycosylated 
capsid that displays uncommon glycoforms only shared by chloroviruses3. The 
identification of the glycoform structure suggest that they are probably 
synthetized by the virus and not by the host. These findings represented the 
starting point to analyse PBCV-1 genome looking for genes encoding those 
enzymes. In the present work, A064R is characterized by enzymatic analysis, 
demonstrating that it is a multidomain enzyme, with two rhamnosyltransferase 
activities and a methyltransferase one. A075L is also demonstrated to be a GT, by 
enzymatic analysis and ITC experiments. Experiments aimed also to identify the 
3D structure of the protein, and to confirm its interaction with the substrate, the 
UDP-xylose. The solving of the 3D structure and the enzymatic characterisation 
are currently underway.  
A064R and A075L enzymes display interesting catalytic properties that could be 
explored for biotechnological applications. In fact, the study of the enzymes that 
process glycans is a recent topic explored for the production of compounds largely 
used as bioactive molecules 4. Identification of novel GTs will provide new tools 
that can expand the biological biodiversity of glycans as bioactive natural products, 
which is well known to participate in the molecules drug efficiency in terms of 
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pharmacokinetics and pharmacodynamics4, and that could be also exploited for 





1.1 Glycans, N-Glycosylation and glycosyltransferases 
1.1.1 An overview of glycans 
Glycans characterize every free-living cell in a multicellular organism. They cover 
the cell surface forming the so-called glycocalyx in eukaryotic cells, and they have 
an active role in several biological processes, including the infection by viruses, 
bacteria and parasites. Glycans also actively participate in the protein folding and 
quality control. The important role of glycans in human physiology is highlighted 
by the fact that defects on glycosylation processes result in pathologies classified 
as Congenital Disorders of Glycosylation (CDG) 5.  
In Eukaryotic organisms, glycosylation is a post translational mechanism that 
originates in the ER-Golgi system and proceeds through the Golgi cisternae (also 
named the secretory pathway). Glycosylation of membrane proteins participates 
in cell-cell (or cell-pathogen) recognition and cell-matrix interaction, while 
glycosylation of secreted proteins may provide solubility, hydrophilicity and 
negative charge, thus reducing unwanted nonspecific intermolecular interactions 
in extracellular spaces and protecting against proteolysis. Glycans on secreted 
molecules may also act as decoys, binding pathogens that seek to recognize cell-
surface glycans to initiate invasion6. 
In Bacteria, Archaea, and Fungi, glycans have critical structural roles in forming the 
cell wall and ensuring the correct osmolarity between the cytoplasm and the 
environment. Glycans surrounding bacteria could also have a role in defence 











Figure 1. Type of glycans and the Re-Golgi pathway. (a) N-linked glycans, 
glycosaminoglycans and glycosphingolipids are located on cell surface proteins, 
hyaluronic acid is a component of external matrix, while O-linked glycans are usually 
situated on soluble proteins. (From Moremen et al.) (b) Initiation and maturation of the 
major types of eukaryotic glycoconjugates in relation to sub-cellular trafficking in the ER-
Golgi–plasma membrane pathway. In addition to N-glycosylation, there are also O-
glycosylation, glycosammination, the GPI anchor synthesis and the glycosphingolipids 
synthesis. (From Varki et al.6) 
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Glycosylation is considered the most complicated post translational modification 
because of the number of reactions involved. Indeed, glycosylation molecular 
events include production of the donor substrates (either nucleotide-sugar or lipid 
linked precursors), its transfer to the nascent oligosaccharide chains and the 
trimming and the remodeling of the glycan, to obtain the final structure. Unlike 
other cell processes such as transcription or translation, glycosylation is non-
templated, and thus all of these steps do not necessarily occur during every 
glycosylation event, amplifying the diversity of the final product7. 
As previously mentioned, in Eukarya through the ER-Golgi pathway proteins are 
modified by glycosyltransferases that transfer the lipid-linked precursor or an 
activated monosaccharide to a specific amino acid residue of the protein or to a 
growing glycan. Glycosidases catalyse the hydrolysis of glyosidic bonds to remove 
sugars from a glycan structure and finally,  glycan-modifying enzymes transfer 
different groups from a specific donor to the glycan7.  
The Figure 1 describes the different type of glycans and glycosylation processes 
among ER/Golgi system. N-glycans and glycosylphosphatidylinositol (GPI) 
anchors, a lipid anchor for many surface proteins, are initiated by the en-bloc 
transfer of a large preformed precursor glycan to a newly 
synthesized glycoprotein. O-glycans and glycosaminoglycans are initiated by the 
addition of a single monosaccharide, followed by sequential extension. The most 
common glycosphingolipids are initiated by the addition of glucose to ceramide on 
the outer face of the ER-Golgi compartments, and the glycan is then flipped into 
the lumen to be extended6. For more details on the other type of Glycosylation 










1.1.2 Protein N-glycosylation  
 
N-glycosylation is the most highly studied form of protein glycosylation in 
eukaryotic organisms and it has been estimated that approximately half of all 
human proteins are glycoproteins, and most of them contain N-glycan structures6.  
All N-glycans share a common core sugar sequence (Figure 2), Manα1–6(Manα1–
3)Manβ1–4GlcNAcβ1–4GlcNAcβ1-Asn-X-Ser/Thr (and less frequently of Asn-X-Cys 
and other non-standard sequons, where X can be any amino acid except for Pro8), 
and are classified into three types: (1) oligomannose, in which only mannose 
residues are attached to the core; (2) complex, in which “antennae” initiated by 
N-acetylglucosaminyltransferases (GlcNAcTs) are attached to the core; and (3) 
hybrid, in which only mannose residues are attached to the Manα1–6 arm of the 
core and one or two antennae are on the Manα1–3 arm9.  
 
 
Figure 2. N-glycans. N-glycans added to protein at Asn-X-Ser/Thr sequons are of three 
general types in a mature glycoprotein: oligomannose, complex, and hybrid. Each N-
glycan contains the common core Man3GlcNAc2Asn. (From Rini et al.10)  
 
As schematized in Figure 3 and Figure 4, N-glycans are initially synthesized as a 
lipid-linked oligosaccharide (LLO) precursor (the dolichol phosphate or Dol-P in 
Eukaryotes, the undecaprenyl-pyrophosphate or Und-PP in bacteria), and then the 
glycans are transferred during translation from the precursor to a nascent 
polypeptide chain8. The biosynthesis begins on the cytoplasmic face of the ER 
membrane with the transfer of GlcNAc-P from UDP-GlcNAc to the Dol-P to 
generate dolichol pyrophosphate N-acetylglucosamine (Dol-P-P-GlcNAc)9. 
Fourteen sugars are then sequentially added to Dol-P, initially on the cytosolic face 
of ER and then, after flipping, on the ER luminal face. Finally, a multi-subunit 
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oligosaccharyltransferase (OST) on the luminal face of the ER membrane catalyses 
the “en bloc” transfer of the entire glycan to the Asn-X-Ser/Thr sequon on a 
protein that is being synthesized and translocated through the ER membrane 
(Figure 3)8. 
The protein-bound N-glycan is subsequently modified in the ER and Golgi by a 
complex series of reactions catalysed by membrane-bound glycosidases and 
glycosyltransferases. Many of these enzymes are finely sensitive to the 
physiological and biochemical conditions of the cell in which the glycoprotein is 
expressed. Indeed, activity of these enzymes  will depend on the cell type in which 
the glycoprotein is expressed, may be regulated during development and 
differentiation and also it may be altered in disease9,11.  
It is important to note that whereas the presence of the Asn-X-Ser/Thr sequon is 
necessary for the formation of an N-glycan, transfer of the N-glycan to this sequon 
does not always occur, due to conformational state or other constraints 
during glycoprotein folding. Thus, the identity of “X” may reduce the efficiency 
of glycosylation, such as when “X” is acidic (aspartate or glutamate). In addition, 
when Asn-X-Ser/Thr sequons are present in an amino acid sequence, they are not 






Figure 3. Protein N‑glycosylation and quality control of protein folding. The STT3 subunit 
of the oligosaccaridiltransferase, transfers the glycan moiety on the nascent protein. 
Then, by the UGGT1 and the mannose trimmering process, the folding process involves 
lectin chaperons. If the protein could not fold, it is driven to the proteasomal degradation. 
On the contrary, the protein is translocated to the Golgi complex where 
glycosyltransferases will modify the glycans moiety (from Moremen et al.8).  
 
As previously mentioned, the OST transfers the sugar moieties from the Dol-P to 
the nascent protein in eukaryotic cells. In particular, one OST subunit identified as 
STT3, contains the catalytic site of the enzyme. Bacterial glycosylation also relies 
on the transfer of glycans from a lipid-linked precursor to nascent polypeptide 
chains, but the enzyme responsible is a single polypeptide, PglB, with high 
sequence similarity to eukaryotic STT38.  
The initial steps of the formation of the oligosaccharide precursor and its transfer 
on the nascent protein appear to be conserved among all eukaryotes. It is well 
established that the N-linked oligosaccharide has a key roles in protein quality 
process  in the ER, via interactions with ER chaperones and lectins that recognize 
specific features of the trimmed glycan9. This process protects nascent 
polypeptides from hydrophobic aggregation and non-productive disulphide 
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bonding during their folding steps. Iterative cycles of glucose removal by glu-
cosidase II and glucose re-addition by UDP-Glc:glycoprotein glucosyltransferase 
(UGGT1), followed by re-binding to the lectin chaperones calnexin and calreticulin, 
help to facilitate efficient folding of newly synthesized glycoproteins in the ER 
lumen8. In addition, to recruit chaperones during protein folding, glycan structures 
define the ER residence time for the downstream quality control of newly 
synthesized glycoproteins. ER-associated protein degradation (ERAD) is the 
process by which misfolded or unassembled proteins are destroyed in eukaryotic 
cells8. Glycoproteins with slow folding kinetics due to mutation or incomplete 
oligomeric assembly of subunits are targeted for degradation by the activity of 
mannose trimming enzymes, which is the basis of the ‘mannose timer’ model of 
ER quality control. Glycan trimming is followed by recognition of the trimmed 
structures by components of a multiprotein complex at the ER membrane that 
facilitates ‘retro-translocation’ and subsequent proteasomal degradation in a 
process termed as ER-associated degradation (ERAD)8 (Figure 3). This complex 
process involves recognition of degradation signals, dislocation of proteins across 
the ER membrane and degradation by the ubiquitin-proteasome system in the 
cytoplasm8. 
Further processing of the N-linked glycan occurs in the downstream Golgi 
cysternae. Biosynthesis of hybrid and complex N-glycans is initiated in the medial-
Golgi by the action of an N-acetylglucosaminyltransferase called GlcNAcT-I, which 
adds an N-acetyl-glucosamine residue to C-2 of the mannose α1–3 in the core of 
Man5GlcNAc2. Once this step has occurred, the majority of the N-glycans are 
trimmed by α-mannosidase II, another resident enzyme of the medial-Golgi, which 
removes the terminal α1-3Man and α1-6Man residues from 
GlcNAcMan5GlcNAc2 to form GlcNAcMan3GlcNAc2. It is important to note that α-
mannosidase II cannot trim the Man5GlcNAc2 intermediate unless it is first acted 
on by GlcNAcT-I9. Once the two mannose residues are removed, a second N-
acetylglucosamine is added to C-2 of the mannose α1–6 in the core by the action 
of GlcNAcT-II to yield the precursor for all biantennary, complex N-glycans.  
Hybrid N-glycans (Figure 3) are formed if the GlcNAcMan5GlcNAc2 glycan is not 
acted on by α-mannosidase II, leaving the peripheral α1–3Man and α1–6Man 
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residues intact and unmodified in the mature glycoprotein. Incomplete action of 
α-mannosidase II can result in GlcNAcMan4GlcNAc2 hybrids. Another Golgi 
mannosidase, discovered in mutant mice lacking functional α-mannosidase II, is 
termed α-mannosidase IIX and acts on the GlcNAcMan5GlcNAc2 generated by 
GlcNAcT-1. Inactivation of both α-mannosidase II and α-mannosidase IIX in the 
mouse leads to embryos lacking all complex N-glycans9. Complex and hybrid N-
glycans may carry a “bisecting” N-acetylglucosamine residue that is attached to 









Figure 4. The N-glycosylation process among kingdoms. N-linked glycosylation in most 
eukaryotes follows a similar initial processing pathway, that begins with the generation of 
a lipidlinked oligosaccharide (LLO) by multiple asparagine-linked N-glycosylation 
processing enzymes (ALG). The oligosaccharide is then transferred “en bloc” on the 
polypeptide backbone by oligosaccharyltransferase (OST). Proteins are modified at Asn 
residues containing the N-X-S/T sequence. Processing then diverges significantly between 






Further sugar additions (Figure 4), mostly occurring in the trans-Golgi, convert the 
limited repertoire of hybrid and branched N-glycans into an extensive array of 
mature, complex N-glycans. For convenience, this part of the biosynthetic process 
can be divided into three components: (1) sugar additions to the core, (2) 
elongation of branching N-acetylglucosamine residues by sugar additions, and (3) 
“capping” or “decoration” of elongated branches. This steps are fully described 
here by Stanely et al. 9. 
N-glycosylation is not restricted to Eukaryotes, but recent evidences have revealed 
complex mechanism of N-linked glycosylation also in Bacteria and Archaea, 
indicating that this type of modification is universal in all kingdom (Figure 4). In 
Campylobacter jejuni , the bacterium in which the N-glycosylation is deeply 
characterized, an heptasaccharide, the previously mentioned Und-PP, is built on a 
lipid-linked precursor on the cytoplasmic side of the inner membrane 13. The 
resulting lipid-linked oligosaccharide (LLO) is then translocated across the inner 
membrane into the periplasmic space by an ATP-dependent flippase (PglK) and 
transferred to Asn residues in target proteins by a bacterial 
oligosaccharyltransferase (OTase), PglB. The bacterial system requires an 
extended N-glycosylation consensus sequence: Asp/Glu-X1 -Asn-X2 -Ser/Thr, 
where X1 and X2 represent any amino acid except Pro13. Finally, in Bacteria and 
Archea the monosaccharide bound to the Asn side chain is not GlcNAc, but acetyl-






In Eukaryotes most glycosyltransferases have been found to be localized in the ER-
Golgi apparatus, but there are evidences of some cytosolic forms, such as the 
soluble OGT, a protein GlcNAc-transferase responsible for synthesizing the O-
linked GlcNAc of nuclear and cytoplasmic proteins. Other forms of soluble 
glycosyltransferases are actually derived from their membrane-associated forms 
that is cleaved near the transmembrane segment within the stem region (Figure 
5). These proteolytic cleavage events release a catalytically active fragment of 




Figure 5. Golgi organisation and typical transmembrane topology and proteolytic 
processing of Golgi glycosyltransferases. (a) Golgi organelle is organised into three 
compartments: cis, medial and trans. The forward movement of vesicles starts from 
Endoplasmic Reticulum, until cell surface and endosomal compartments. Retrograde 
movement is the opposite (Modified from Tu et al.). (b) The soluble glycosyltransferases 
are cut near the transmembrane domain of the membrane –bound domain (Modified 
from Varki et al.). (c) Glycosyltransferases are composed by the enzymatic C-terminal 
domain that is exposed in the lumen, the transmembrane region and a short N-terminal 
domain that is exposed in the cytoplasm (Modified from Tu et al.14).  
 
As the circulating enzymes do not have access to adequate concentrations of 
donor nucleotide sugars (primarily located inside cells), they should be 
functionally incapable of performing a transfer reaction in the extracellular spaces. 
For this reason, the biological significance of these soluble transferases therefore 
remains a mystery. Possibilities to consider include a lectin-like activity recognizing 
their acceptor substrates and/or a role in scavenging small amounts of 
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circulating sugar nucleotides that might otherwise be available to certain 
microbes, as it was demonstrated for gonococci6. 
As the Figure 5 shows, typically the glycosyltransferases have a single 
transmembrane domain flanked by a short amino-terminal domain and a longer 
carboxy-terminal domain. This structure is characteristic of the so-called type II 
transmembrane proteins. The single amino-terminal membrane-spanning domain 
is a signal-anchor sequence, placing the short amino-terminal segment within the 
cytoplasm, while directing the larger carboxy-terminal domain to the other side of 
the biological membrane into which the signal anchor has been inserted. For 
plasma-membrane-associated type II proteins, the “other side” is the extracellular 
surface, but for glycosyltransferases, the “other side” is the lumen of the ER-Golgi 
pathway. Watching at this arrangement, it is evident that the larger carboxy-
terminal domain contains the catalytic activity of the transferase, and the 
intralumenal location of this domain allows it to participate in the synthesis of the 
growing glycans, during transit of glycoproteins and glycolipids through the 
secretory pathway. 
Generally, the Golgi glycosyltransferases localisation is mediated by different 
factors: the transmembrane domain, the luminally oriented noncatalytic region, 
interactions between catalytic domains, and the cytoplasmic tail. How the 
cytoplasmatic tail can drive Golgi-resident glycosyltransferases and glycosidases is 
not fully understood14. Biochemical and ultrastructural studies indicate that 
glycosyltransferases partially segregate into specifically distinct compartments 
within the secretory pathway. Generally, enzymes acting early in glycan 
biosynthetic pathways have been localized to cis and medial compartments of the 
Golgi, whereas enzymes acting later tend to co-localize in the trans-Golgi cisternae 
and the trans-Golgi network. In fact, the transmembrane domain of the 
Golgi glycosyltransferases  possess a localisation signal and in many cases there 
are also major contributions from the luminal domain15. However, the mechanism 
is much more complicate, because it is also evident that different cell types from 
the same organism can show distinct localization patterns for the same enzyme 14. 
Generally, Coat protein complex I (COPI)–coated vesicles are involved in the 
glycosyltransferases recycling14. The steady-state distribution of these enzymes is 
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maintained by a dynamic process that involves their retrieval from late Golgi 
cisterna (Trans-Golgi) to early cisterna (Cis-Golgi), as well as between the Golgi and 
the ER, then they transit back to the cisterna on which they function. However, 
Golgi-resident glycosyltransferases lack canonical COPI-binding motifs in their 
cytoplasmic tails, but there are other proteins, such as Sft1p, identified by Tu et 
al., that could bind the tails of these enzymes and could facilitate their 
incorporation into COPI-coated vesicles14.  
As glycosyltransferases can exist as monomers, homo-dimers, hetero-dimers, or 
hetero-oligomers, the glycosyltransferase associations appear to contribute to 
both the localization of these enzymes in the Golgi as well as to their enzymatic 
activity. At this point, homo-complexes, but more importantly hetero-complexes, 
play important role in the Golgi localisation. For example, the hetero-complexes 
allow glycosyltransferases to work in series as the product formed by one member 
of the complex serves as a substrate for another member14. As a demonstration 
of that, the sequential action of Mannosidase II (ManII) and N-acetylglucosaminyl 
transferase I (GlcNAcT1) is crucial to the synthesis of N-linked glycans in 
mammalian cells. In this way, the localization of one enzyme can influence the 
localization of the other 14 .  
Actually, the formation of glycosyltransferase oligomers is not necessarily a 
prerequisite for proper localization, and therefore aggregation cannot account for 
the localization of all enzymes: the stem region and/or the transmembrane region 
and the physiochemical environment of particular cisternae may also influence the 
ability of glycosyltransferases to form oligomers as well as protein localization. 
This transition is highly dependent on the acidic Golgi microenvironment. 
Chloroquine, a pH gradient dissipating drug, markedly inhibited heteromer 
assembly in live cells16. Hassinen et al. demonstrated that after de novo synthesis, 
glycosyltransferase polypeptides form homodimers during their folding and/or 
before their transport to the Golgi. In the Golgi, the acidic luminal milieu favors 
the formation of heteromers among sequentially acting medial-Golgi or trans-
Golgi enzymes at the expense of enzyme homomers. Nocodazole inhibits this 
process due to its ability to block anterograde transport and coalescence of 
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transport vesicles into a compact Golgi structure. Cloroquine was used to show 
that this transition is a pH-dependent process 16.   
 
Glycosyltransferases structure and enzymatic mechanism 
 
Glycosyltransferases comprise a large family of enzymes that share common 
features. The cloning and sequencing of more than 500 genomes has now shown 
that glycosyltransferases are a diffused enzyme type, representing 1–2% of the 
genes. More than 30,000 glycosyltransferase sequences are known across all 
kingdoms, and they comprise approximately 90 glycosyltransferase families 
defined by primary sequence analysis10,17,18 
Despite the large number of sequence families that have been defined, structural 
analysis has shown that glycosyltransferases possess a limited number of fold 
types. To date, structures for members of 29 of the 90 families have been 
determined by X-ray crystallography, defining the GT-A or GT-B folds for the so-







Figure 6. Glycosyltransferases topological domains. The GT-A-fold is a single catalytic 
domain arranged into two closely β/α/β Rossman domains. The GT-B-fold enzymes 
possess two distinct domains separated by a cleft that binds the acceptor in the middle. 
(From Rini et al.10). 
 
GT-A-fold enzymes  are composed by a single catalytic domain arranged into two 
closely β/α/β Rossman domains19, which are found in proteins that bind 
nucleotides and are responsible for interaction with the nucleotide sugar donor 
substrate10,19. The GT-A enzymes have been found to possess a DXD motif, a short 




GT-B-fold enzymes possess two distinct domains separated by a cleft that binds 
the acceptor. The carboxy-terminal domain is primarily responsible for binding the 
nucleotide sugar donor substrate, but both domains possess elements similar to 
those of the Rossman fold. The GT-B glycosyltransferases are often metal-ion 
independent and do not possess a DXD motif 10,19. 
Leloir type glycosyltransferases transfer a nucleotide-activated sugar to the 
nascent glycan moiety. The activated donor sugar substrate contains a 
(substituted) phosphate leaving group; in fact, they are nucleoside diphosphate or 
monophosphate sugars (e.g., UDP-galactose, GDP-mannose, CMP-sialic acid). 
Finally, glycosyltransferases use as acceptor substrates oligosaccharides, 
monosaccharides, polypeptides, lipids, small organic molecules, and even 
DNA19,10.  
As previously described, these enzymes act sequentially, so that the product of 
one enzyme yields the acceptor substrate for the subsequent action of another. 
The end result is a linear and/or branched polymer composed of monosaccharides 
linked to one another10.  
 
 
Figure 7 . Glycosyltransferases catalyse glycosyl group transfer with either inversion or 
retention of the anomeric stereochemistry, with respect to the donor sugar. In the 
inversion stereochemistry, the enzyme uses an SN2 reaction, while the retention 





As shown in Figure 7, glycosyltransferases catalyse their reactions with either 
inversion or retention of stereochemistry at the anomeric carbon atom of the 
donor substrate.  In the inversion stereochemistry, the enzyme uses an SN2 
(substitution nucleophilic bimolecular) reaction mechanism where the acceptor 
performs a nucleophilic attack at carbon C-1 of the sugar donor.  Typically, 
enzymes of this type possess an aspartic acid or glutamic acid residue whose side 
chain serves to partially deprotonate the incoming acceptor hydroxyl group, 
rendering it a better nucleophile. In addition, these enzymes promote catalysis by 
features that help to promote leaving-group departure. In the GT-A enzymes, a 
metal ion is bound by the DXD motif and it is typically positioned in the way to 
interact with the diphosphate moiety. The positively charged metal ion serves to 
electrostatically stabilize the additional negative charge that develops on the UDP 
leaving group during bond breakage10.  
The retention reaction follows the so-called SNi mechanism. In this case, the 
incoming nucleophile attacks from the same side as the leaving group. It means 
that the leaving group departure and nucleophilic attack occur in a concerted but 
asynchronous manner on the same face of the glycoside10. 
Many glycosyltransferases have been shown to possess a Bi-Bi sequential kinetic 
mechanism in which the donor substrate binds before the acceptor substrate, and 
the glycosylated acceptor is released before the nucleoside monosphosphate or 
disphosphate, depending on the reaction. To better explain this structural model, 
the active site represents a deep pocket, with the nucleotide sugar substrate at 
the bottom and the acceptor substrate stacked on top. If the acceptor substrate 
binds first, it would sterically preclude donor substrate binding. Necessarily, 
release of the glycosylated product must precede release of the nucleoside 
phosphate. Although largely consistent with such a model, the X-ray crystal 
structures of glycosyltransferase-substrate complexes also shows that substrate-
dependent ordering of flexible loops is a feature common to glycosyltransferases. 





The Biotechnological interest in Glycosyltransferases 
 
The study of glycosyltransferases is of particular biotechnological interest because 
of the functional contribution of carbohydrates as biologically active natural 
products. Actually, there are several glycosides produced by microorganisms and 
plants which are used as drugs in the treatment of different diseases20. 
Moreover, as the therapeutically relevant natural products are glycosylated, and 
because of the sugar residues attached to such natural products by 
glycosyltransferases are typically indispensable for biological activity, the exact 
identity and pattern of glycosyl moieties can influence 
pharmacology/pharmacokinetics, invoke biological specificity at the 
molecular/tissue/organism level, and even define the precise mechanism of 
action. This fact, coupled with the importance of natural products in drug 
development, has spurred the development of both chemical and enzymatic 
methods for glycosylating natural products21. 
Functional characterisation of each glycosyltransferase is required to explore the 
potential of these enzymes for the derivatisation of glycosylated natural products 
and with the advent of molecular tools and recombinant methods it is now 
possible to engineer novel natural product derivatives.  
In the biosynthesis of bioactive natural glycosides, glycosyltransferases are often 
involved in the last-step modification of an aglycon, leading to the corresponding 
ultimate bioactive molecules. However, the substrate specificity of 
glycosyltransferases provides a critical issue in natural product diversification, and 
scientists have started recently to broaden the specificity by genetic engineering34. 
Recently, glycosyltransferases with broad tolerance, especially towards the sugar 
donor, have been identified and characterised making them valuable as tools, for 
example, in antibiotic remodeling20.  
To date, carbohydrate vaccines are used in vaccines industry. Usually, they are 
directly purified from the target microorganism and the presence of impurities 
(such as cell-wall polysaccharides) are coisolated, with the risk of 
hyperresponsivity and other side effects 22,23. The isolated polysaccharides are 
structurally heterogeneous, and they require multiple purification and quality 
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control steps before that the antigen can be formulated in a vaccine. Efforts to 
improve the efficacy and safety of these vaccines are important to achieve 
comprehensive vaccination and eradication of the respective pathogens.  
Synthetic oligosaccharides based on the repeating units can be an attractive 
option to furnish vaccines free of contaminants that have predictable clinical out-
comes.  An interesting approach, that will avoid the copurification of impurities 
from microorganisms or the difficulties linked to the chemical synthesis, could be 
the in vitro production of oligosaccharides by using recombinant 
glycosyltransferases. However, most glycosyltransferases are membrane bound 
and difficult to produce as soluble enzymes in E. coli. The viral glycosyltransferases 
from giant viruses studied in this work  are soluble enzymes and can be produced 
in large amount and this peculiarity could be exploited in the production of 









1.2 Nucleo cytoplasmic large DNA viruses 
 
“Giant viruses sound like something from a scifi flick. But they're real and 
not as scary as you think”. 
Jim Van Etten 
 
1.2.1 Evolution theories and families of Nucleo 
Cytoplasmic Large DNA Viruses 
 
Viruses were always considered as not “live” organisms, but such as entities 
composed by a capsid (and an envelope in most cases) that contains the genetic 
material (DNA or RNA). As suggested by Patrick Forterre24, viruses are viewed also 
as “side-products of cellular evolution”. But now, in the recent 20 years, viruses 
are the center of many debates on the early evolution of life on our planet and the 
question “are viruses alive?” is at the center of this debate. For many years the 
answer to this question was negative, considering viruses as “escaped genes” from 
cellular organisms24. 
Viruses infect organisms in all superkindoms of life (Bacteria, Archaea and 
Eukaryotes) and replicate in all cell type25. Their extreme diversity suggests that 
they must have had a multiple evolutionary origin. According to Iyer et al 26, there 
are two major group of theories for virus evolution: the first one places viruses in 
the earliest phases of life’s evolution and associate them with the primitive 
precursors of cellular systems.  The second group of theories consider viruses as 
secondary derivatives of cellular systems that underwent to a drastic degeneration 
as a consequence of extreme parasitism. Moreover, viruses are seen as “break 
away” elements from cellular genomes that survived as minimal parasitic 
replicons26.  
The first decade of viral comparative genomics unifies viruses on the basis of the 
evolutionarily conserved proteins of their replicon apparatus 26. Here we find the 
division between retroviruses, that use retrotransposons and a reverse 
transcriptase as their principal replicon polymerase, and DNA viruses, with their 
related plasmids and transposons, that use replication endonucleases 26. Inside 
these two big classifications, there are several monophyletic groups with common 
ancestors, as the Nucleo Cytoplasmic DNA Viruses (NCLDVs)26. However, the 
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higher order relationship between various groups of large eukaryotic DNA viruses 
remain uncertain.  
NCLDVs are a group of DNA viruses infecting diverse hosts and that share common 
ancestry. Eight families that infects eukaryotes (algae, animals and protista) have 
been recognized, represented by Poxoviridae that infect vertebrates and 
invertebrates, Asfaviridae that infect vertebrates, Iridoviridae and 
Phycodnaviridae that are aquatic viruses, Ascoviridae, Marseilleviridae, 




Figure 8. The eight families of NCLDVs classified so far. (A) Mimivirus (Modified from 
Wilson et al28.) (B) Phycodnavirus (Modified from Wilson et al28.) (C) Pithovirus (Modified 
from Abergel et al29.) (D) Marseillevirus (Modified from Okamoto et al30.) (E) Ascovirus 
(Modified from Wilson et al28.) (F) Iridovirus (Modified from Wilson et al28) (G) Asfavirus 
(Modified from Wilson et al28.) (H) Poxovirus (Modified from Jha et al.31). 
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Mimivirus (Figure 8, panel (A)) is the first giant virus that was discovered in 1992 
by Timothy Robotham, a microbiologist at Leeds Public Health Laboratory1. In 
2003 Mimivirus was isolated and sequenced after the observation, thanks to 
electron microscopy techniques, that it was not a “clamidia-like” bacteria, but a 
giant virus with 1.1 megabases of genome and 0.7 µM of dimensions.29  Mimivirus 
is characterized by an icosahedral  capsid of about 400 nm of dimensions, 
surrounded by 150 nm of thick fibril layer with a composition similar to 
peptidoglycan, except for a five-pronged star structure in a vertex defined as 
“stargate”29. This structure is used by the virus to fuse with Acanthamoeba 
membrane and inject the viral nucloide inside the host cytoplasm29.  
Mimivirus genome analysis was not able to places it in the known domains of life, 
suggesting an independent evolution from a different ancestor that belongs to a 
new undefined tree32. The new, fourth, domain of life is strongly debated on both 
technical and biological aspects, evolving into a quasi-philosophical debate on the 
nature of viruses, as previously mentioned in this chapter: “are viruses alive?” and 
“could viruses, in principle, belong to a tree of life?”24,27. Starting from Mimivirus, 
a lot of NCLDVs are then discovered, isolated and genome sequenced, as briefly 
described in this chapter. But recently, the interest in giant viruses is grown also 
thanks to the discovery of viriophages, small dsDNA viruses classified as 
Lavidaviridae that parasitize Mimivirus and reproduce in its viral factories and can 
block its growth, partially defending the Amoeba host27,33. This finding, and other 
characteristic such as genome size and viral particle dimensions, define Mimivirus 





Figure 9. The family relationships among NCLDVs members are represented by the 
phylogenetic reconstruction of universally conserved NCLDVs proteins: DNA polymerase, 
major capsid protein, packaging ATPase, A-18 like helicase, Poxovirus late transcription 
factor VLTF3 . The branch colour indicates confirmed or likely hosts: red Amoebozoa; 
green other protists; blue Metazoa. The tree reconstruction is a phylogeny obtained with 
an updated, representative set of NCLDVs according to the new discoveries. It consists in 
three big branches: families of Mimiviridae and Phycodnaviridae, families of  Pithoviridae, 
Marseilleviridae, Iridoviridae and  Ascoviridae, and finally   families of  Poxoviridae and 






Poxviruses (Figure 8, panel (H))  infect animals and replicate entirely in the 
cytoplasm. 34 They possess a unique icosahedral capsid characterised by brick-
shaped virions. They are classified in a clade that contains also Asfavirus 27 (Figure 
8 panel (G)). As described by Koonin et al27, the switch from protists to animal 
hosts seem to be appeared twice in this branch. Finally, Poxvirus contains genome 
that spaces from 130 to 360 kb 27 (Table1). 
Asfavirus are in the same clade of Poxoviruses with share common characteristics 
such as the icosahedral envelope and the cytoplasmic replication. They infect 
amoebae and animals and possess dsDNA of 170-470kb27,35 (Table1). 
Iridovirus (Figure 8, panel (F)  are in the same branch of Ascovirus (Figure 8, panel 
(E))  , Marseillevirus (Figure 8, panel (D))   and Pithovirus families (Figure 8, panel 
(C), and Figure 9). 32 Based on phylogenic studies, Iridoviruses and Asfaviruses 
evolved from Phycodnaviruses, and the Ascoviruses evolved from Iridoviruses36. 
Iridoviruses infect insect and cold-blooded vertebrates and have genome of about 
250kb with icosahedral capsid. They can replicate in both host nucleus and 
cytoplasm32 (Table1). 
Ascoviruses produce virions that are reniform or bacilliform and cause fatal 
disease in their insect hosts27,36. They have a 150kb DNA and replicate in nucleus 
and cytoplasm 33 (Figure 8, panel (E), Table1). 
Pithoviruses have an amphora-shaped form and infect probably protist. They 
were discovered using the same protocol for coculturing acanthamoeba and 
Pandoravirus, by which was confused thanks to the same viral dimensions and 
shape29. Pithoviruses have the largest virions among all known virions with 
genome that can reach more than 1400kb 27 (Figure 8, panel (C), Table 1). 
Marseillevirus is one of the last NCLDVs discovered and it is  recently established 
that is a member of the amoebal NCLDVs. 30 The virions shows ichosaedral capsid 
that can vary from 190 to 250 nm, but the anatomic and genic carachteristics place 
them in a unique family 30 . Finally, the Marseillevirus genome span around 350kb 
and replicate in host nucleus and cytoplasm (Table 1)27. 
Phycodnaviruses (Figure 8, panel (B))  that infect the green algae Chlorella 
variabilis 28, hold genome size until 400 kb and replicate in both nucleus and 
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cytoplasm. Phycodnavirus, and more specifically PBCV-1, is the main object of this 
thesis and will be discuss largely in the next pages (Table 1). 
Recently, some new viruses have been discovered. More precisely, they are 
Faustovirus, Mollivirus and Pandoravirus (Figure 10). 
 
 
Figure 10. New NCLDVs. (A) Faustovirus. (B) Mollivirus. (C) Pandoravirus. Scale bar: 200 
nm. (Modified from Fisher et al37.)  
 
Pandoravirions (Figure 10, panel (C)), recently classified id the Pithovirus family, 
(Figure 8) have a novel type of morphology, consisting of 1 mm by 0.5 mm ovoid 
particles with a single apical pore, needed for genome delivery. Comparative 
genomic analyses confirmed that Pandoraviruses are unrelated to Mimiviruses, 
but they share a few genes with algae-infecting phycodnaviruses37. The main 
peculiarity of Pandoravirus is a compartment between two layers, resulting in a 70 
nm tegument like envelope of three layers 29. Finally, Pandoravirus DNA consists 
of about 3 Mbp. 29 
From Siberian permafrost (dated to be 30 000 years old), two novel types of giant 
viruses were isolated on Acanthamoeba hosts. Pithovirus sibericum (Figure 8 panel 
(C)) displays an elongated particle with a length of 1.5 mm and a diameter of 0.5 
mm, which resembles pandoravirions, but are structurally unrelated. 
Phylogenetically, this virus shows a remote relatedness to irido- and ascoviruses.  
The second novel type of giant virus that was isolated from permafrost soil is 
Mollivirus sibericum (Figure 10 panel (B)), not assigned to any family yet, with 
previously unseen morphology. They are spherical, 0.6 mm in diameter, and 
covered with a ‘hairy’ tegument that can be from two to four 29,37. Mollivirus apex 
aperture consists then in a funnel of about 200 nm in diameter29. 
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 Another described addition to the NCLDV group is Faustovirus (Figure 10 panel 
(A)), which was isolated on Vermamoeba vermiformis, an amoeba that is 
commonly found in human environments. Although the ‘Faustovirus’ capsids 
(about 200nm) have the typical icosahedral symmetry also found in the amoeba 
infecting mimiviruses or marseilleviruses, their 466 kb genome encodes several 
proteins with phylogenetic affinity to asfarviruses (African swine fever virus).  
Origin and evolution of NCLDVs is still unclear. Surely, there is a group of genes 
that, for the majority, are of eukaryotic origins and just a minority of them are 
from a bacterial and archaeal descendent. For this reason, it is supposed that they 
have coevoluted during eukaryogenesis. Lineage- specific gene loss and gain 
within NCLDVs families has led to the highly diverse properties of present-day 
viruses25. In the beginning of 2000s, the  evolution of NCLDVs was supposed to 
come from a single ancestor, thanks to the observation of a core gene set of about 
50 genes 25,26. More recently, it is suggested by Koonin et al. that giant viruses have 
encountered a dynamic evolution, and not from a single anchestor27. According to 
the first vision of NCLDVs evolution, the first 50 genes might be retained or 
discarded in a distinctive evolutionary traceable pattern that could be mapped to 
the genome of the common ancestor of this class of eukaryotic viruses1,25,28. Also, 
according to Claverie et al. as they supposed in the first decade of 2000, giant 
viruses must come from a cellular ancestor that could not be assigned to any of 
the three domains of life, but from a separated fourth one38. This finding came 
primarily from the observation that, mapping Mimivirus DNA, it is represented by 
a complex genome  not characterised by accumulation of random DNA segments 
(like in bacteria) or particularly enriched with mobile elements, palindromic 
structures, or genes encoding the necessary enzymatic equipment (transposases, 
integrases...)38. Moreover, as usually happens for conventional viruses, there is no 
presence of lateral gene transfer in the so far studied Mimivirus genome (and later 
for the others)38. The concept of a fourth domain of life has been promoted 
starting from 2011 from different scientist, with a new concept of NCLDVs 






Table 1. NCLDVs families with unrelated groups. The table shows the main NCLDVs 
characteristics in terms of host, genome size, virion architecture and replication site. 






Figure 11.  Different viral genomes size comparison. Mimivirus is a giant among giant 
viruses, with a diameter of 750 nanometers. It possesses a very big genome comparing to 
viral standards, of 1.2 million base pairs, coding for 1,018 genes. For comparison, the 
smallest free-living bacterium, Mycoplasma genitalium, is just 450 nanometers in 
diameter and possesses a genome half the size of that in mimivirus, coding just 482 
proteins. The record tiniest cellular organism, Hodgkinia cicadicola, a parasite in cicadas 
that was described in 2009, has a genome of just 140,000 base pairs, coding a paltry 169 





Figure 12. A schematic representation of the probable scenario of evolution of DNA viruses 
and other DNA-based replicons proposed by Iyer et al. in the first 2000s. On the left are 
pointed some of the major transitions in evolution. On the right are briefly described the 
major innovations entailed by each transition. DNA genomes are colored red, 





Figure 13.  Iyer et al propose also a phylogenetic tree of the NCLDVs, built on the basis of 
conserved gene set analysis. The number of proteins reconstructed as being present in 
the ancestral core of a clade of viruses is shown next to the blue circles. Shown in brackets 
are the numbers of proteins that are unique to a particular clade. Proteins that are 
predicted to be part of the ancestral NCLDV genome are shown on the left. Protein names 
in red and marked with an asterisk represent members of the ancestral genes set that 
have not been identified in previous reconstruction of the author. The transcription factor 
A7L protein was formerly called the ASFV-B385R-like protein (abbreviations: THP, 
Terminal hairpin; TIR, Terminal inverted repeats; CPTR, circularly permuted terminally 








As previously mentioned, the new vision of NCLDVs evolution proposed by Koonin 
et al. 27 suggests a dynamic evolution instead of an evolution from a single 
ancestor, thanks also to the discovery of new species of giant viruses that allowed 
to amplify the NCLDVs genome analysis and knowledge.  In the model proposed 
and well explained by bioinformatic analysis, the NCLDVs pangenome (the entire 
set of genes for all strains in a clade), is “heavily dominated by ORFans and genes 
that are conserved in small groups of viruses only”, infact, the overlap between 





Figure 14. Differently from how it was proposed from Iyer et al in 2001, that suggested a 
NCLDVs evolution from a single ancestor, later in 2006 it is proposed a multiple coevolution 
from at least three different organisms. This finding came from the observation that there 




To explain this dynamic evolution, Koonin et al. suppose that both gene gain and 
gene loss might be occurred (Figure 15)27. In prokaryotes, losses are more 
common than gains, differently from how it probably happened in NCLDVs 
evolution where gains are prevailing. This observation is confirmed by the 
likelihood reconstruction of genome evolution along the tree of the nearly 
universal genes in giant viruses27. As described above, and how it is possible to 
observe in Figure 15, in NCLDVs there is a lineage specific gains rather than losses 
of ancestral genes. For this reason coupled with the small overlapping of genes 
between NCLDVs genomes, it is supposed an evolution from at least three 
independent occasions, differently from  the previous proposed view 25,26. 





Figure 15. Gene gain and gene loss in NCLDVs evolution. Red triangles represent gene loss 
while green triangles gene gains. It is also possible to appreciate the three main branches 




The large genome of NCLDVs comprises proteins with cell like proprieties that give 
a partial independence from the cell host. For instance, it is demonstrated that 
they possess the replication machinery, proteases, part of the translation system, 
enzymes involved in redox reactions and, of particular interest, the enzymes 
involved in glycosylation and modification of glycans 39. This viewpoint is 
important comparing NCLDVs to common viruses, which despite the enzymes 
needed for the infection and, in some cases, DNA replication and translation, they 
are totally dependent from the host.  
NCLDVs replicate exclusively in the host cytoplasm or start their life cycle in the 
host nucleus and complete it in the cytoplasm, as evidenced for Mimivirus and 
Phycodnaviridae 26,40,41. In addition, they typically do not exhibit much 
dependence on the host replication or transcription systems (as usually viruses do) 
because irradiation of host nucleus does not inhibit replication of viruses, as 
Professor Van Etten demonstrated for Paramecium bursaria Chlorella virus – 
1(PBCV -1) 42.  In line of that, the NCLDVs encode several conserved proteins that 
mediate most of the processes essential for viral reproduction. 
As previously mentioned, NCLDVs infect animals, algae and Protista and their 
peculiarities are a high genome complexity and notable viral particle dimensions. 
As an example, PBCV– 1 displays a 300 kb DNA that encodes for 400 proteins and 
200 nm of capsid, comparing to Herpesvirus or HIV that are smaller in terms of 
genome and viral particle dimensions 28. As a demonstration of that, the first giant 
virus discovered was exchanged for a bacterium by GRAM + staining.  
Given their unusual properties for a virus, like their morphology, ecology, genome 
size and gene uniqueness, a new name was proposed for the giant viruses, that is 
“giruses”. The semantic and scientific goal of the new name1 was to emphasize 
the unique properties of large DNA viruses, which likely represent a unique and 
shared evolutionary history.  
In addition, even if several viral hallmark genes are shared by NCLDVs and other 
large DNA viruses, such as herpesviruses and baculoviruses, the conservation of 
the entire set of core genes clearly demarcates the NCLDVs as a distinct class of 
viruses, as will be fully described in the next pages43 . According to this findings, 
more recently, thanks also to the discovery of new species and the demonstrated 
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evolutionary reconstruction, an official taxonomic rank of the NCLDVs has been 
proposed, as the order of “Megavirales” referring to the large size of the virions 
and genomes of these viruses 44. 
NCLDVs reserve a well-defined structure inside the cytoplasm where all those 
mechanisms needed for the viral assembly take place. These structures are 
defined as “virus factories”45, which are considered a peculiarity of dsDNA viruses 
that infect eukaryotic organisms. Virus factories are isolated structures in the cell 
host cytoplasm were all the mechanisms needed for new virion assembly occur. 
These compartments create a significant evolutional advantage to the virus, 
because adequate spatial coordination of viral genome replication and assembly, 
with maximum efficiency in the use of cell resources, and allow viruses to hide 
from host cell antiviral defenses46.  
The most studied NCLDVs virus factories are the one of Mimivirus, which infects 
Amoebae,  and PBCV-1 that infects Chlorella variabilis40,45. The main goal for the 
viral infection is the injection of the viral DNA into the host cytoplasm. Mimivirus 
releases its DNA into the host cytosol after opening the so-called “stargate” and 
fusing the virion membrane with the one of the phagocytic vesicles. DNA 
duplication occurs directly in the host cytoplasm and all the processes (replication, 
transcription and new virion assembly) take place here40. On the other hand, it has 
been recently established that PBCV -1 uses a “bacteriophage-like strategy”, 
where its genome is injected into the cytosol by a spike, while the virion is attached 
to the host surface. Then, the DNA migrates into the nucleus, where it replicates 
using the host machinery, and subsequently it is driven to the cytoplasm 41.  
As briefly described above, NCLDVs comprise eight families: Poxoviridae, 
Asfaviridae, Iridoviridae, Phycodnaviridae, Ascoviridae, Marseilleviridae, 
Pithoviridae  and Mimiviridae. More focus will be dedicated to Chloroviruses, 






1.2.2 Phycodnaviridae: Chloroviruses and Paramecium 
bursaria Chlorella virus – 1 as a viral model. 
The literal translation of Phycodnaviridae is “DNA viruses that infect algae”28. 
Viruses infecting eukaryotic algae are huge dsDNA viruses with genomes ranging 
from 160 to 560 kb with up to 600 protein-encoding genes 47.  
Phycodnaviridae are found in aqueous environments throughout the world. They 
also seem to have a dynamic role in regulating algal communities, such as the 
termination of massive algal blooms commonly referred to as red and brown tides 
47,48. PBCV-1, which is the most studied Phycodnaviridae, is a large, icosahedral, 
plaque-forming virus that replicates in chlorella-like green algae (for this reason it 
is classified as a chlorovirus) and its structure, its initial stages of infection and 
many of its genes resemble  bacteriophages47. In addition, Chlorovirus hosts are 
normally symbionts with the protozoan Paramecium bursaria, the coelenterate 
Hydra viridis or the heliozoon Acanthocystis turfacea47. 
Members of the Phycodnaviridae are currently grouped into six genera (named 
after the hosts they infect): Chlorovirus, Coccolithovirus, Prasinovirus, 
Prymnesiovirus, Phaeovirus and Raphidovirus. Complete genome sequences have 
been obtained from representatives of the Chlorovirus, Coccolithovirus and 
Phaeovirus genera and evolutionary analysis of their genomes places them as 
Nucleo Cytoplasmic Large DNA Viruses28, described before in this chapter. 
Despite the wide host range of Phycodnaviridae, all members have similar 
structural morphology, and this is consistent with a common ancestry. Data 
obtained on PBCV-1 demonstrated that virions are large layered structures of 
about 100-220 nm in diameter with a dsDNA-protein core surrounded by an 
icosahedral capsid that covers a single lipid bilayered membrane, which is required 







Figure 16. (a) Chlorovirus (left) and Coccolithovirus (right) as two examples of 
Phycodnaviridae (Modified from Van Etten et al., and Wilson et al.). (b) Three-dimensional 
image reconstruction of chlorella virus PBCV-1. The virion capsid consists of 11 
pentasymmetrons and 20 trisymmetrons (Modified from Stass et al.). (c) Schematic 
representation of PBCV-1 envelope.  The membrane is surrounded by a capsid with an 
icosahedral symmetry (T=169), 100-220 nm in diameter (From 
https://viralzone.expasy.org/145).  
 
As described by Van Etten et al., one of the PBCV-1 capsid vertice shows a long 
spike-structure that forms a closed cavity inside a large pocket between the capsid 
and the membrane where the viral DNA is packed. The capsid shell consists of 1680 
donut-shaped trimeric capsomers plus 11 pentameric capsomers, one at each 
icosahedral vertex except for the spike-containing vertex. The trimeric capsomers 
are arranged into 20 tri- angular facets (trisymmetrons, each containing 66 
trimers) and 11 pentagonal facets (pentasymmetrons, each containing 30 trimers 
and one pentamer at the icosahedral vertices (Figure 16). External fibers extend 
from some of the trisymmetron capsomers (probably one per trisymmetron) and 
presumably aid in virus attachment to the host 47.  
PBCV-1 major capsid glycoprotein is Vp-54, with a predicted mass weight of 48,165 
kDa, reaching to 53,79 kDa with posttranslational modifications. It consists of two 
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eight-stranded, antiparallel β-barrel jelly-roll domains. Vp-54 represents the 40% 





Figure 17. Representation of PBCV-1 major capsidic glycoprotein and its glycoforms. Vp-
54 is a protein of about 48 kDa and consists of two eight-stranded, antiparallel β-barrel 
jelly-roll domains. It represents the 40% of the total proteins and identities of the other 
virus surface proteins are unknown. The two major glycoforms identified so far are N-
linked glycans identified only in PBCV-1. (Modified from De Castro et al49.). 
 
The Vp-54 crystal structure49 (with PDB code 5TIQ) in  Figure 17  reveals four N-
linked glycans attached to the protein, that are recently determined by detailed 
chemical, spectroscopic, and spectrometric analysis50,51. Previous studies 
incorrectly identified also two O-linked glycans, but without the solved glycan 
structure, they were just “fixed” in the density X-ray map49.  Recently the old data 
have been reviewed, refining these observations and confirming the presence of 
only the four N-linked glycans49.  
The glycan portion of Vp-54, which is oriented to the outside of the particle, 
contains seven neutral sugars: glucose, fucose, rhamnose, galactose, mannose, 
xylose, and arabinose28. However, the four glycosylated Asn residues are not 
located in the typical prokaryotic and eukaryotic N-linked glycans consensus 
sequences Asn-X- (Thr/Ser)28,50. In addition, the structure of the Vp54 glycoforms 
are unique and do not resemble any type of structure reported so far for any 
organism in the three domains of life and in NCLDVs too. In fact, the N-glycans of 
all chlorella viruses have a new structural core that do not resemble any other 
reported for bacteria, archea or eukarya, thus it can be considered a signature for 





Figure 18. Different glycoforms among Chlorovirus.  Each glycoform is classified according 
to the Chlorella host infected (NC64A, OSy, Pbi, SAG). (From Speciale et al51.) 
 
In particular, the oligosaccharide is linked to the Asn residue by a β-glucose; this 
type of linkage is very rare, and it is found so far only in some Archea and Bacteria. 
The oligosaccharides are highly branched, with a fucose substituted at all available 
positions; each glycan contains two rhamnose residues with opposite 
configurations (abbreviated as L-Rha or D-Rha) plus a further terminal L-Rha 
capped with two O-methyl groups (diO-Me-L-Rha). Two monosaccharides, 
arabinose and mannose, occur as nonstoichiometric substituents, resulting in four 




Glycoform 1 is a nonasaccharide. It possesses all the monosaccharides except Ara, 
and it is the predominant form at Asn-302, Asn-399, and Asn-406. Glycoform 2 is 
a decasaccharide, it includes Ara, and it is the predominant form linked at Asn-
28049. 
As Figure 17 shows, the structure of these N-glycans consists of two regions: the 
core region is located near the protein backbone and is highly conserved among 
the chloroviruses3,49. It consists of the N-linked glucose, two xylose units [one 
located close (proximal unit or Xylprox) and one far (distal unit or Xyldist) from the 
protein backbone], the hyperbranched fucose and a galactose. The second region 
extends the conserved core with other monosaccharides, which are specific for 
each chlorovirus3,49. All these N-glycans are unique and do not resemble any 
known eukaryotic  or prokaryotic glycan, prompting interest in viral glyco-releated 
genes3,49.  
In the recent years,  this finding together with other observations  led to the 
conclusion that PBCV-1 as other members of NCLDVs 39 encodes at least part, if 
not all, of the machinery required to glycosylate its major capsid protein 
independently from the host endoplasmic reticulum-Golgi system 3,28,50. This is a 
peculiarity of the NCLDVs that is giving a growing interest to the study of those 
viruses and that define them as partially independent eukaryotic parasites. In fact, 
as a support of this thesis, PBCV-1 it is demonstrated to possess own 
glycosyltransferases that synthetize the glycoforms52.  
As described in a detailed review from Wilson et al, the PBCV-1 virion contains 
more than 110 different virus-encoded proteins and about 700 ORFs28. But, 28in 
order to maximise the space inside the virion, viruses typically have compact 
genomes that help replication efficiency. Phycodnaviruses fit this pattern with 
approximately one gene per 900 to 1000 bp of genomic sequence28. The 366 PBCV-
1 protein-encoding genes are evenly distributed on both strands and, with one 
exception (a 1788-nucleotide sequence near the middle of the genome), 
intergenic space is minimal. In fact, 275 ORFs are separated by fewer than 100 
nucleotides. The 1788-nucleotide DNA region, which contains many stop codons 






Figure 19. SDS-PAGE separation and PBCV-1 genome mapping. (Modified from Van Etten 
et al47.).  
 
Some of the Phycodnaviruses genomes have methylated bases. For example, 
genomes from 37 chlorella viruses contain 5-methylcytosine (5mC) and N6-
methyladenine (6 mA) that occur in specific DNA sequences. However, it was a 
surprise to discover that approximately 25% of the virus-encoded DNA 
methyltransferases have a companion DNA site-specific (restriction) 
endonuclease. Thus, the virus-infected chlorellae are the first nonprokaryotic 
source of DNA site-specific endonucleases28. 
Sequencing of Phycodnavirus genomes showed genes not previously found in 
viruses that may provide clues as to their niche adaptation. As an example, it is 
possible to recognize a sphingolipid biosynthesis pathway in coccolithovirus Ehv-
89, the previously mentioned sugar metabolism in PBCV-1, the enzymes involved 
in the degradation of host cell wall (chitinases,  chitosanase,  β-l-3 glucanase and 
enzyme that cleaves polymers of either β-or α-l,4-linked glucuronic acids) and 
enzymes involved in polyamine biosinthesys found again in PBCV - 128. 
As previously described, PBCV-1 replication strategy involves host cytoplasm and 
nucleus, in a partial different way used by Mimivirus. PBCV-1 infection starts with 
the attachment of the virus to the algae cell wall, in an irreversible way (Figure 20, 
panel (a) and (b)). This host-virus recognition is immediately followed by the DNA 




the nucleus41. The transcription of early genes starts 7 min PI (post infection), and 
the DNA synthesis 60 min PI in the nucleus, where the first structural evidence of 
infection is observed: deformed morphologies of host nuclei were detected, as 
those of infected cells lose their spherical shape and assume elongated or 
crescent-like morphologies, revealing enhanced heterochromicity (areas near the 
nuclear membrane that are heavily stained for DNA)6 (Figure 20 panel (c) and (d)). 
Such modified nuclear structures reflect extensive degradation of host DNA45.  
 
 
Figure 20. PBCV-1 major infection stages. first the virus binds the host cell wall where it 
injects the DNA. Then, after the DNA translocation to the nucleus, it is driven to the 
cytoplasm where there is the assembly of the viral factories. After new viral particle 
assembly, the virus ejects from the cell in a cell litic way (Modified from Milrot et al41., 
and Kang et al53.). 
 
Differently from the Acanthamoeba- infecting Mimivirus, Chlorella membranes 
play a central role in the assembly of the structure of PBCV – 1 cytoplasmic virus 
factories, detected at 2h PI (Figure 20, panel (e) and (f)). Sequential tomography 
slices in Figure 20 show early viral factories as rosette-like crescent structures that 
consist of two distinct layers characterized by different densities: an external 
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angular capsid shell and an internal membrane bilayer, where host ribosomes and 
other organelles are excluded, probably for the massive accumulation of new 
progeny virions45. Factory generation is sided by massive accumulation of the host 
membrane cisternae that partially surround the viral factories and, in some cases, 
deeply penetrate the factory cores. These cisternae appear to bud out from rough 
endoplasmic reticulum (ER) membranes and they are derived mainly from outer 
membranes of host nuclei41. In contrast to Mimivirus and Vaccinia virus viral 
factories, cores of PBCV-1 factories consist of membrane structures surrounded 
by viral genomes. Moreover, in the viral factories, it is possible to see the different 
virion assembly stages starting from crescent-shaped structures, partially 
assembled particles lacking DNA and mature virions. Mature virions are forced 
away from the viral factory core presumably by the progressive and continuous 
generation of new progeny viral particles45 (Figure 20 panel (e)). At 3h PI the host 
cytoplasm appears to be full of viral DNA that is located at viral factory periphery 
and, at the same time, host nuclei is completely empty of host DNA, in agreement 
with the demonstration that host DNA is degraded after virus infection by viral 
endonucleases, and the synthesis of new viral particles is driven by viral proteins45. 
Other members of Phycodnaviridae are not well studied as PBCV-1, but of 
particular interest is the Coccolithovirus with its mentioned spingolipid 
byosinthesis pathway. Coccolithovirus infects a marine microalgae with global 
distribution, identified as Emiliana huxley28. The prototype specie of the genus 
Coccolithovirus is EhV-86   and, as all the Phycodnaviridae and NCLDVs, it possesses 
a large genome54. 
The Coccolithovirus sphingolipid biosynthesis pathway is important for its 
infection strategy that involves unique mechanisms for replication, survival, 
defence, evolution, dissemination, and communication55. In particular, it is 
demonstrated to possess genes involved in the synthesis of ceramide, a 




1.3 Glycosylation in NCLDVs 
 
As largely described in the previous chapter, NCLDVs display some eukaryotic 
characteristics that are uncommon in viruses. In addition to the large dimensions 
in terms of DNA and viral particle, NCLDVs possess proteins that allows them to be 
partially independent from the cell host and permit to drive all the host resources 
to feed their pathways25. The viral particle assembly take place in defined zones in 
the host cytoplasm known as “virus factories”, described above, where possibly 
the viral protein glycosylation take place39. 
In fact, together with genes involved in DNA replication, protein synthesis and 
different type of posttranslational modifications, genome sequencing of NCLDVs 
also revealed the presence of several genes involved in glycosylation, including 
glycosyltransferases and other carbohydrate-modifying enzymes. In addition, as 
described by Piacente et al., genomes of large DNA viruses often present enzymes 
responsible for the production of the nucleotide-sugars that are the substrates for 
glycan formation 39.  
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1.3.1 Chlorovirus glycosylation and nucleotide sugar 
biosynthetic pathways 
 
Several nucleotide-sugars biosythetic pathways have been identified in NCLDVs. 
The GDP-L-fucose pathway was first described in PBCV-1 by Tonetti et al in 200352.  
Since then, enzymes involved in the hexosamine pathway, D- and L-rhamnose and 
D-viosamine have been found56. Moreover, genome inspection of most reported 
members of the Phycodnaviridae reveals the possible presence of many other 
putative enzymes involved in nucleotide-sugar production.  
PBCV-1 encodes two enzymes involved in the nucleotide-sugar biosynthetic 
pathways: a GDP-D-mannose 4,6-dehydratase (GMD, a118r gene), and a NADPH-
dependent bifunctional GDP-4-keto-6-deoxy-mannose epimerase/reductase 
(GMER, a295l gene). GMD produces the unstable intermediate GDP-4-keto-6-
deoxy-mannose from the GDP-D-mannose, and GMER which catalyses the 3,5-
epimerization followed by a NADPH-dependent reduction of C-439 (Figure 21). 
 
 
Figure 21. Metabolism of GDP-D-rhamnose and GDP-L-fucose in PBCV-1. Both GMD and 
GMER have two activities: PBCV-1 GMD with both dehydratase and NADPH-dependent 
reductase activities, leading to GDP-D-rhamnose formation. GMER is a GDP-4-keto-6-






BLAST analysis indicates that both GMD and GMER are conserved in most 
Chloroviruses sequenced so far, suggesting an essential role of this pathway in viral 
replication. Actually, GDP-L-fucose is produced by chlorella hosts, however, the 
cytosolic amounts of this nucleotide are usually low and GMD, the limiting step of 
the pathway, is subjected to strong feed-back regulation by its products. Indeed, 
L-fucose is an important component of the PBCV-1 glycan core structure and, as 
consequence, the pathway is probably used to circumvent a limited supply of GDP-
L-fucose, which might limit the oligosaccharide synthesis39.  
In PBCV-1 and in some other closely related Chloroviruses, GMD is also a 
bifucntional enzyme, displaying also a NADPH-dependent reductase activity on C-
4 of the intermediate compound obtained through its dehydratase reaction. This 
leads to the formation of GDP-D-rhamnose. This bifunctional activity of PBCV-1 
GMD is not observed for  the enzyme encoded by other Chloroviruses, such as 
ATCV-1 30 .   This is consistent with the finding that D-rhamnose is a component of 
the variable region of PBCV-1 glycan, but it is not found in ATCV-1 and most other 
members of this genera 39  
UGD, the UDP-D-glucose dehydratase that is the first enzyme of the L-rhamnose 
pathway, is found only in ATCV-1 and other few isolates, all infecting Chlorella 
heliozoae, the endosymbiont of Acanthocystis turfacea. The second enzyme of the 
pathway, a bifunctional epimerase/reductase is absent in ATCV-1. In fact, UDP-L-
rhamnose is commonly produced by plants and L-rhamnose synthesis has been 
demonstrated to occur in Chlorella algae. Since UGD represents the limiting step 
for UDP-L-rhamnose production, it is possible to hypothesize that the enzyme was 
acquired by the virus to prevent feed-back inhibition and increase the nucleotide-
sugar supply. In addition, it has to be noted that genes encoding UGD-like proteins 
are not present in sequenced chloroviruses infecting other hosts, suggesting that 
this enzymatic activity is not essential for all chlorella viruses39. 
PBCV-1 and several other chloroviruses induce the formation of an extracellular 
polysaccharide, either hyaluronan or chitin, a short time after infection. Two 
enzymes involved to overcome a limited supply of the two precursors for the 
hyluronan biosynthesis are found in PBCV-1 genome: a100r gene product is a 
functional glutamine-fructose-6P aminotransferase (GFAT), which catalyzes the 
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first step for the de novo UDP-D-N-acetylglucosamine (UDP-D-GlcNAc) pathway, 
and a609l gene product, that is a UDP-D-glucose dehydrogenase (UGDH), which 
promotes the NAD+-dependent oxidation of glucose C-6, leading to the UDP-D-
glucuronate formation39. 
PBCV-1 genome has been demonstrated  to encode at least 6 glycosyltransferases 
genes: A064R, A111/114R, A075L, A546L, A219/222/226R, A473L (Figure 22) .2 
These glycosyltransferases are predicted to be soluble proteins and located in the 
host cytoplasm51. Interestingly, the six encoded glycosyltransferases of PBCV-1 do 
not justify the complexity of its glycan structures; an explanation is that some of 
the glycosyltransferases display more than one GT domain. Another possibility is 
that viruses encode for proteins that cannot be predicted as glycosyltransferases 
just by sequence comparison, so they could be overlooked during the data base 
searches. In addition, some host glycosyltransferases could be recruited for the 




Figure 22. PBCV-1 Vp-54 major representative glycoform. On the glycoforms 
are signed the putative glycosyltransferases suggested to be responsible of the 












Figure 23. Glycan structures of WT and selected antigenic mutants of PBCV-1. Antigenic 
classes are labeled with a capital letter (A–D and F), and the structure of their glycans 
depends on the kind of mutation found in the genome, which in all cases, except for 
Classes C and D, occurs in the gene a064r. EPA1 (antigenic Class B) and E11 (antigenic Class 
C) have identical mutations in domain 1 of a064r, but E11 has an additional mutation in 
gene a075l. P91 has an additional glycoform with -L-Rha methylated at O-2 (From Speciale 
et al51.). 
 
To date, the only gene products for which the enzymatic activities have been 
confirmed are PBCV-1 hyaluronan synthase (HAS, a98l gene product) and CVK2 
chitin synthase (CHS). In addition, two chlorovirus putative glycosyltransferases 
have been crystallized, a064r N-terminal domain gene product from PBCV-1 and 
b736l gene product from the related NY2A strain. The A064R N-terminal domain 
shows a GT-A fold 57 (PDB code: 2P73) similar to retaining glycosyltransferases, 
while the C-terminal domain resembles an O-methyltransferase. Indeed, the a64r 
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gene is restricted to few viral species and it is even absent in viruses closely related 
to PBCV-1.  
The second chlorovirus glycosyltransferase for which the structure has been 
determined is b736l gene product from PBCV-NY2A virus infecting Chlorella 
variabilis NC64, that is well conserved in viruses infecting  Chlorella variabilis39. 
The features of the putative PBCV-1 glycosyltransferases have been determined 
also  thanks to the study of Vp-54 glycoforms and the identification of mutant 
variants, represented in Figure 2351.   As reported by Speciale et al51, PBCV-1 
spontaneous mutants are divided in to six antigenic classes denoted with a letter, 
based on their differential reaction to five different polyclonal antibodies. An 
exception is Class E that cross-react with Class A and B polyclonal antibodies, 
suggesting that the phenotypes of class E variants shares some of the structural 
features of the other two variants51. It is important to note that five of the six 
classes have mutation in the A064R gene. Indeed, the mutants lacks some sugars 
of the N-glycan moieties51.  
Secondly, another approach for the identification of PBCV-1 glycosyltransferases 
is based on genome comparison of the genomes of all Chlorovirus identified so 
far2. As already mentioned, all Chlorovirus glycans share a common core structure. 
With this approach, some genes encoding enzymes possibly involved in the glycan 
core formation have been identified, including a111/114r and a075l2. 
A111/114R is a protein of 860 amino acids organised into three domains, where 
the second one is annotated as a glycosyltransferase. A111/114R has a possible 
role in the core glycan assembly and attachment. Indeed, this gene is not affected 
by the large genomic deletion of the serological mutants reported in Figure 23. 
Since it is the only annotated orthologous glycosyltransferase gene found outside 
the deletion regions in mutants, it is present in all Chloroviruses  and it was not 
possible to identify viable mutants for the gene, this led to the conclusion that is 
responsible for the formation of the core N-glycan and that this portion is the 
minimal required for virus viability, even if its role is still unclear51.  
According to the mutant analysis, A071R is supposed to attach the α,3 D-rhamnose 
to the α,3 fucose51. In addition, it is classified as a glycosyltransferase even if does 
not displays any resemblance in the database, except of domain 2 of A064R that 
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is also not been annotated but there is strong evidence that it is a 
glycosyltransferase (see results section)51. 
Moreover, by genetic analysis of the mutants, A075L is supposed to attach the 
distal xylose. The evidence came from the N-glycan variants from Class C, that 
lacks this xylose and display a mutation in the a075l gene51. With the same kind of 
observation, A064R domain 1 and 2 are classified as rhamnosyltransferases51.  
A064R variants displaying mutations in the C-terminal domain lack the methyl 
groups on the last L-rhamnose, suggesting the enzymatic activity of the protein, 
and are classified in the Class F genetic variants. Even if PBCV-1 encodes many DNA 
methyltransferase genes, the only mutated methyltransferase gene in the 
antigenic variant is in the C-terminal domain a064r. The best hit in a BLAST search 
of the WT amino acid sequence of domain 3 to the nucleotide database at NCBI 
was to 2’-O-rhamnosylmethyltransferases. Indeed, when the rhamnose 
methyltransferase from Mycobacterium smegmatis was BLASTED against the 
PBCV-1 protein database, the only hit was to domain 3 of A064R (33% identity and 
49% positive). Consequently, when a064r is mutated in the third domain, the 
corresponding N-glycan is not methylated at either the O-2 or O-3 position, 
suggesting that this methyltransferase can perform a double methylation of the 
monosaccharide. However, we cannot exclude the possibility that domain 3 
attaches only one methyl group and that a second methyltransferase, yet to be 












1. Experimental  
Procedures 
 
1.1 Gene cloning in pGEX-6P1 vector 
All the sequences are obtained from NCBI: the sequence identifier for A064R is 
AAC96432.1 with Gene ID: 918349 and for A075L AAC96443.1 with Gene ID: 
917877. Sequences were analysed using the BLAST tool.  
The full length A064R gene, cloned in pDEST42-V5-His vector, was kindly provided 
by Professor Van Etten from the University of Nebraska. Primers were designed to 
clone each domain separately in pGEX-6P1, by restriction cloning with BamHI and 
XhoI enzymes (NEB). A scheme of the cloned sequences is shown in the Results 
section. The Q5 High fidelity DNA polymerase (NEB) was used to amplify the 
fragments of interest, following the supplied protocol: initial denaturation 98°C 
for 30 seconds, [98°C 10 for seconds, annealing temperature  (see Table 3) for 30 
seconds, 72°C for30s/kb] repeated for 35 cycles, final extension at 72°C for 2 
minutes.  The annealing temperature for each fragment is displayed in Table 2. 















F AATT ggatcc ATGACCACACCTTGTATTAC 
1230 
BAM HI 39 
R AATT ctcgag TTAATTTTTGTACACAGGGT  XHO I 37 
A064R D1 
+ D2 long 
F AATT ggatcc ATGACCACACCTTGTATTAC  
1329 
BAM HI 39 
R AATT ctcgag TTAGGTTTCCTCCGTCGAGG XHO I 45 
A064R D1 
F AATT ggatcc ATGACCACACCTTGTATTAC 
648 
BAM HI 39 
R AATT ctcgag TTAAGTTGCTACCATCTCCA XHO I 40 
A064R D2 
short 
F  AATT ggatcc ATGTGCGGTACTTCTCGTGC 
651 
BAM HI 47 
R AATT ctcgag TTAATTTTTGTACACAGGGT XHO I 37 
A064R D2 
long 
F AATT ggatcc ATGTGCGGTACTTCTCGTGC 
750 
BAM HI 47 
R AATT ctcgag TTAGGTTTCCTCCGTCGAGG XHO I 45 
A064R D2 
long 2 
F AATT ggatcc ATGGTAGCAACTGGTGAAAT 
714 
BAM HI 41 
R AATT ctcgag TTAGGTTTCCTCCGTCGAGG XHO I 53 
 






A064R D1 + D2 short 52 
A064R D1 + D2 long 54 
A064R D1 54 
A064R D2 short 52 
A064R D2 long 60 
A064R D2 long 2 56 
 
Table 3. PCR condition for A064R gene domains. 
 
A075L gene was amplified using PBCV – 1 DNA, kindly provided by professor Van 
Etten, University of Nebraska. PCR amplification was performed as indicated 















F AATT gatccATGAAGCTCGCCGAACTTAC 
810 
BAM HI 44 
R AATTctcgagTTACTGACTATATTCGAGAA XHO I 34 
 

























Figure 24. pGEX-6p1 vector map from snapgene.com. 
 
pGEX-6p1 is a prokaryotic expression vector: it displays a 4984 bp sequence that 
contains ampicillin resistance and the N-terminal GST (Gluthatione S- transferase) 
tag. GST is a small protein of 25 kDa that, thanks to its solubility, helps the 
recombinant protein purification. In addition, it is also possible to monitor the 
protein purification procedure with the CDNB assay that, in the presence of 
glutathione (GSH) and 1-chloro-2,4-dinitrobenzene (CDNB), allows to follow the 
kinetics of increase of absorbance at 340 nm. In addition, the protein of interest is 
recovered, after the affinity binding to the GSH-resin, by a specific proteolytic site 
between GST and the protein of interest, using the Prescission Protease (GE 
Healthcare). Prescission Protease is a genetically engineered fusion protein of 
human rhinovirus 3C protease and GST that specifically cleaves between the Gln 
and Gly residues of the recognition sequence LeuGluValLeuPheGln/GlyPro. 
After PCR amplification by the high-fidelity DNA polymerase, the correct length of 
the products was analysed by 1.5% agarose electrophoresis. For A064R, for which 
the pDEST-V5-His vector was used as template, a further incubation with 1 U/50µl 
of DpnI enzyme (Roche) was performed for 1 hat 37°C after the end of PCR cycles, 
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in order to ensure complete removal of the template vector. PCR products were 
then purified using the “PCR clean-up kit” (Sigma). After purification, the amplified 
DNA was subjected to restriction digestion for 1 h at 37°C, using BamHI and XhoI 
enzymes (NEB). The products were purified again after the end of incubation, by 
the “PCR clean-up kit”. 
The pGEX-6p1 vector was digested using the same protocol. Complete digestion 
of the vector was verified by agarose electrophoresis. A following 
dephosphorylation step, using Antarctic phosphatase (NEB), was added after 
digestion. Restriction enzymes and phosphatase were inactivated as indicated by 
manufacturer’s instructions.   
Ligation was performed using the “Quick transformation kit” (Roche), following 
the provided instructions. The ligation product was also analysed by 1% agarose 
electrophoresis. 
 TOP10 E. coli cells were transformed with 2 µl of the ligation product, directly 
added to 100 µl of the competent cells: cells were then incubated for 30 min on 
ice. Then, to facilitate vector entry, heat shock at 42°C was applied for 45’’, 
followed by 2 min on ice. SOC medium (1 ml) was added and cells were incubated 
on a rotary shacked for 1h at 37°C. The cell suspension was then centrifuged at 
2500 rpm for 10’ and resuspended in 300 µl of SOC medium, which was then 
spread on LB agar plates and incubated at 37°C overnight. 
The day after, some colonies were chosen to be verified by PCR followed by 1,5% 
agarose electrophoresis of the amplification product. One colony that resulted 
positive for the right insert was then grown in 5 ml medium overnight. The vector 
was purified with the Miniprep kit from Sigma and sequenced. The verified vector 
was transformed into BL21 competent cells, using the procedure describe above, 
with a heat shock at 42°C for 30‘’, for expression of the recombinant protein. Full 
length A064R cloned in pDEST64-V5-His was transformed in BL21-DE3 cells, using 







1.2.1 Expression and purification of the recombinant 
proteins: A064R full length and A064R domains 
 
Bacterial growth and lysate preparation 
A 10 ml starter culture was grown overnight at 37°C. The day after, it was diluted 
1:100 in fresh medium; cells were grown for approximately 8 hours at 20°C until 
OD600 was 0.4 – 0.6. Protein expression was induced with 0.1 mM IPTG (Sigma) 
overnight, in vigorous shaking at 18°C, with humid air bubbling. 
The bacteria were recovered by centrifugation at 7000 rpm for 15 min, then the 
pellet was re-suspended in lysis buffer.  For the full length A064R, which is 
produced with a C-terminal 6XHis tag, 50 mM sodium phosphate buffer containing 
500 mM NaCl, pH 8.0, 5 mM imidazole, was used for cell resuspension. Conversely, 
E. coli cells expressing the GST-fusion domains were re-suspended in PBS (50µl /L 
of the initial culture volume). Cells were disrupted by sonication (10 cycles of 10s 
on/10s off repeated 3 times) and, for the proteins produced with the GST tag, 1% 
Triton X-100 was also added and incubated for 30 min at 4°C with gentle agitation, 
to promote protein release from cell debris. Then, the insoluble fractions were 
removed by centrifugation at 12 000 x g for 25 min. 
 
Purification of recombinant proteins: 6xHis tag expression system (A064R full 
length) 
The supernatant obtained after lysis and the last centrifugation step was 
incubated in batch with 1 ml with a nichel affinity resin (Probond) for 350 ml of 
the initial bacterial culture: beads were pre-equilibrated with binding buffer (50 
mM Na phosphate buffer, 500 mM NaCl, 5 mM imidazole, pH 8.0) for 1 h at 4°C 
with gentle agitation. At the end of this incubation time, the beads were packed 
in a 15 ml column and the flow through, which corresponds to the unbound 
proteins, was collected for further analysis. The column was washed with 10 
volumes of wash buffer (50 mM Na phosphate, 500 mM NaCl, pH 8.0, 20 mM 
imidazole); then the protein was eluted with wash buffer supplemented with 250 
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mM imidazole. The eluted fractions containing the recombinant protein were 
recovered and concentrated using the Millipore Centrifugal units, cut off 10 KDa, 
by centrifugation at 2800 rpm, until a final volume of 500 µl was reached. 
Purification of recombinant proteins: GST tag expression system, A064R gene 
domains 
The supernatant was initially tested for GST activity, following manufacturer’s 
instructions, and it was incubated with 1 ml of GSH Sepharose (GE Healthcare) for 
350 ml of initial bacterial culture, to affinity capture the protein of interest. The 
binding to the beads was carried for 1 h at 4°C in gentle agitation. The beads were 
then packed into a 15 ml column and the flow through devoid of the GST-fusion 
protein was recovered for further analysis. The GST assay was repeated on the 
eluate, in order to calculate the extent of binding of GST-fusion protein the resin. 
The beads were washed with 10 volumes of PBS, then with 5 volumes of cleavage 
buffer (150 mM NaCl, 50 mM Tris/HCl pH 7.5) and finally they were recovered 
from the column with 15 ml of cleavage buffer; the protein of interest was then 
cleaved from the GST-tag, by addition of 1 mM DTT and of Prescission Protease 
(5µl/ml of GSH-Sepharose used; GE Healthcare) in batch, at 4°C overnight in gentle 
agitation.   
The day after, the resin was again packed in a 15 ml column and the flow throw 
with the recombinant protein was recovered and concentrated using the Millipore 
Centrifugal units, by centrifugation at 2800 rpm, until a final volume of 500 µl was 
reached. 
For some experiments, the GST-fusion proteins were not cleaved and released 
from the resin, but after the last wash the immobilized proteins were directly 








1.2.2 Enzymatic Characterization 
 
D1 and D2 are putative UDP-rhamnosyl transferases. These domains, as it will be 
detailed in the Results section, were cloned separately or together; for the second 
domain, different length of the sequence was cloned, in order to define the 
minimum sequence needed for the enzymatic activity.  
To test the enzymatic activities, in collaboration with Professor Cristina De Castro 
from the University Federico II in Naples, a synthetic acceptor named “Todd” was 
produced by Prof. Todd Lowarty at the University of Alberta. This compound 
displays the distal xylose of the PBCV-1 glycoform, as shown in Figure 29 in the 
Results section. Both activities were tested in the presence or absence of cations 
or of chelating agent EDTA. The reaction mixtures (1.5 mM “Todd”, 1.5 mM UDP-
L-Rha, 2 mM Mg 2+ or Mn2+) were carried out in PBS overnight (O.N.) at 30° C with 
the protein still bound to the resin beads; samples were collected at T0, T4h and 
TO.N. The conversion of the acceptor substrate to the product was verified by HPLC 
using a C18 column with 70% MeOH as eluent (flow rate at 0.8 mL/min; 10 µL: 
volume of each injection). The eluate was monitored by a refractive index 
detector.  
The activity of D3 domain is supposed to be a methyltransferase able to attach the 
distal methyl groups on the last L-rhamnose residue. This domain has not been 
produced alone as yet; however, preliminary tests were performed incubating the 
full-length protein with “Todd” as acceptor and a fivefold excess of S-Adenosyl-
methionine (Sigma), with the protein bound to the resin beads. 
To conform the identity and linkage configuration of the products of D1, D2 and 
D3, NMR analysis was performed on the overnight reaction, after a Sep-Pak 
column purification to remove cations. This step was essential to remove 
especially manganese which is paramagnetic and prevents products analysis via 
NMR. The Sep-Pak cartridge was first activated, following manufacturer’s 
instructions; the scheme of elution was: 20 mL of water; 20 mL of 
acetonitrile/water in 1:4 ratio, 8 mL of acetonitrile, 20 mL of ethanol. 
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All proton NMR were recorded in D2O at 310 K on a Bruker DRX-600 MHz 
instrument equipped with a cryo-probe. Standard Bruker software, Topspin 3.1, 






1.3.1 Expression and purification of the recombinant 
protein 
 
For A075L purification, slight modifications were added to the GST standard 
protocol in order to increase protein recovery and purity, that is a mandatory 
condition for X-ray crystallography experiments. In addition, A075L was also 
produced in a selenomethionine enriched media (SeMet A075L) in order to obtain 
the substitution of Met residues in the sequence. This step is necessary to solve 
the 3D structure after the x-ray diffraction. Expression, purification and further 
analyses of the protein were performed at the Cristallography platform under the 
supervision of Dr. Adriana Rojas, at CiC Biogune in Bilbao, Spain.  
Bacterial growth  
An overnight culture was diluted 1:100 in six flasks with 2 litres of Luria Bertani 
(LB) media each. As the pGEX-6p1 uses Ampicillin as selection marker, 100 μg/ml 
of this antibiotic were added to the media. The growth was carried at 37°C until 
an OD600 0.6 was reached, then protein expression was induced with the addition 
of 0.5 mM IPTG overnight at 18°C.   
For the production of the SeMet protein, cells were initially grown in the LB media, 
(4 liters total), then bacteria were recovered by centrifugation when the OD600 
reached 0.6, and washed twice with ice cold PBS  and placed in  a minimum media 
(SeMet Medium Base (Sigma) supplemented with nutrients (Molecular 
Dimension) and without methionine, at 37°C for 1h. Then the protein expression 
was induced with 0.5mM of IPTG overnight at 18°C and Se-Met at final 
concentration of 40 µg/ml was added. After protein purification describes below, 
SeMet A075L is verified by MALDI-TOF in order to confirm the incorporation of the 
SeMet in the protein. For the MALDI-TOF a C4 microcolumn desalting method was 
used prior to analysis, with 70% acetonitrile and 30% of H2 O as eluent. 
Bacterial cells were recovered by centrifugation at 7000 x g for 25 minutes, then 
the pellets from 4 litres culture were re-suspended in 150 ml of PBS. Cells were 
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lysed by sonication (10s of burst and 59 sec off. 8 min with 60% of amplitude), then 
cell homogenate was clarified by centrifugation at 20 000 x g for 40 min.  
Purification of the recombinant protein 
About 1ml of Glutathione Sepharose 4B resin (GE Healthcare) for each liter of 
culture medium used for bacterial growth were pre-equilibrated with PBS; the 
clarified supernatant was incubated with the beads for 1.5 hour at 4°C in gentle 
agitation. The beads were then washed with 500 ml of PBS and, subsequently, the 
fusion protein GST A075L was eluted in batch with 4 column volumes of 20 mM 
GSH in PBS, at room temperature, for 20 minutes. Proteolytic cleavage of the GST 
tag and removal of GSH used for elution were performed together: briefly, 50 U/ 
µl of Prescission protease were added to the eluted fusion protein with 1 mM DTT 
and the resulting solution was dialyzed overnight at 4°C against 1 L of cleavage 
buffer (50 mM Tris-HCl, 150 mM NaCl, 1mM DTT).  
The day after, the solution containing the recombinant A075L released from GST 
was incubated in batch for 2h at 4°C with 7 ml of GSH beads, using gentle agitation, 
in order to capture the cleaved GST and the Prescission protease. At the end of 
the incubation time the beads were transferred in a 50 ml glass column (BioRad) 
and the flow through containing A075L was collected. This procedure was 
performed twice, to ensure complete removal of the GST- containing 
contaminants. 
To remove other possible contaminating proteins, A075L was diluted 3 times with 
Q buffer A (50 mM Tris-HCl, pH 7.5, 1 mM DTT) and it was then loaded in a 5ml Q 
HP (GE Healthcare) anion exchange column using an AKTA FPLC system. Elution 
was carried on with a gradient from 0% to 50% of Q buffer B (1M NaCl, 50 mM 
Tris-HCl pH 7.5, 1 mM DTT) in 10 CV (column volumes). Protein elution was 
monitored at 280 nm. Fractions containing A075L protein were pooled together 
and concentrated with centrifugal Millipore filter units (cutoff 10 KDa) before 




1.3.2 Enzymatic characterization 
 
Since A075L is a putative UDP-xylosyl transferase, the enzymatic activity was 
tested in the presence of UDP-D-xylose (Carbosynth) and different acceptors. 
Initially, L-fucose was used as single monosaccharide and also as octyl-fucose. 
However, no activity could be observed in these conditions. As consequence, 
preliminary experiments were done using the Vp54-associated glycan of E11 
PBCV-1 variant. This variant (see introduction section) lacks the two distal L-
rhamnose residues and the distal xylose. The glycopeptide was obtained after 
isolation of Vp5458, by thermolysin digestion and purification to obtain the pure 
glycopeptide. Due to the very low amounts of the glycan acceptor, the reaction 
was carried out in the presence of the cations Mg2+ and Mn2+ and with the protein 
in the soluble form.  
 
1.3.3 A075L Substrate Binding reactions 
 
The substrate binding reactions for A075L were performed at CiCBiogune in 
Bilbao(spain) with the collaboration of Professor Jesus Jimènez Barbero, and the 
crystallization experiments were also performed at the crystallography platform 
of CiCBiogune, under the supervision of the platform manager Dr. Adriana Rojas. 
 
Isothermal Titration Calorimetry ITC 
To demonstrate that A075L is effectively able to bind UDP-Xylose as a substrate, 
Isothermal Titration Calorimetry (ITC) was used. ITC technique is highly sensible 
and allows to understand if the active site of an enzyme is able to interact with the 
putative substrate, measuring small variations of the temperature (endothermic 
or exothermic) due to the binding of the molecule in the active site.   
The instrument consists of two cells. One cells contains the macromolecule, and 
in the second cell the ligand is injected with a syringe. Both cells are kept at steady 
temperature and pressure 57. 
When the ligand solution is injected into the cell, the ITC instrument detects heat 
that is released or absorbed as a result of the interaction. This is done by 
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measuring the changes in the power needed to maintain isothermal conditions 
between the reference and the sample cell.  
The heat change is calculated by integrating the power over the time (seconds) 
that gives the enthalpy of the reaction. The heat discharged or consumed during 
the calorimetric reaction corresponds to the fraction of bound ligand. The 
increased ligand concentration leads to saturation of substrate and finally less 
heat is discharged or consumed 57. 
Injections are performed repeatedly, and they result in peaks that become smaller 
as the biomolecule becomes saturated. If no interaction exists between the 
molecules, the peak sizes remain constant and represent only the heat of dilution.  
Once titration is completed, the individual peaks are integrated by the instrument 
software and presented in a Wiseman plot. An appropriate binding model is 
chosen, and the isotherm is fitted to yield the binding enthalpy ΔH, the KD and the 
stoichiometry. The main aspect that needs to be considered, is the appropriate 
concentration of ligand and protein. 
All ITC measurements were carried out at 25 °C on a Microcal PEAQ-ITC (Malvern). 
The ITC data were processed using Origin software (OriginLab Corp., USA). Before 
the ITC analysis, A075L protein (155 µM) was dialyzed overnight in phosphate 
buffer with 1 mM MnCl2 or MgCl2; the next day the UDP-xylose was also diluted in 
the same buffer.  
For these experiments the ligand (1mM UDP-xylose) was titrated with the protein 
used at 100 µM concentration. In total 19 injections with spacing of 180s were 
performed; the first injection of 0.4 µl was not used in data fitting, the following 
injections contained 2 µl of 1 mM UDP-xylose.  
Nuclear Magnetic Resonance  
NMR instrument (Buckner 600) was used in order to confirm the binding between 
substrate and protein. The reactions were set up using 45 μM of protein and 1mM 
of UDP-xylose in the presence or absence of cations at 1mM and also with the 




Finally, a Saturation Transfer Difference (STD) experiment was performed in order 
to understand the ligand binding epitope, the part of the ligand in contact with the 
protein.  From NMR data we calculate the % of STD as an estimation of protein-





1.3.4 A075L Crystallization procedure 
 
Crystallization  is a process by which atoms or molecules are highly organized into 
a structure known as a crystal. The principle that influences the crystal formation 
is the searching of parameters that influences such process. Then, this multiple set 
of factors allows to yield the crystal59.  
A crystal is a solid composed of a regulatory repeated arrangement of atoms 
defined as unit cell. When the structure of one unit cell is clarified, the entire 
structure will be understood. Then, the X-ray diffraction briefly described below, 
gives complete information of the unit cell dimensions59. 
Protein crystals are made of approximately 50% solvent (that can vary from 25% 
to 90%) and the protein that occupies the remaining volume. The entire crystal is 
consequently an ordered gel permeated by extensive interstitial spaces through 
which solvent and other small molecules can diffuse59. The pursuit of protein 
crystallisation usually requires the identification of chemical, biochemical and 
physical conditions that allows to yield some crystalline material, and the 
systematic alteration of these conditions that allows to obtain optimal samples for 
diffraction analysis. First, the crystallisation conditions are set up as a systematic 
variation of the most important variables such as pH conditions, precipitants etc. 
then, once some crystals (or microcrystals) are observed, the optimisation starts, 
and every component of the solution must be considered (buffer, salts, ions…)59. 
Crystals formation goes through different stages: supersaturation, nucleation and 
the effective growth (that is strictly linked to nucleation) 59. Nucleation is the first-
ordered phase transition by which protein molecules pass from a complete 
disordered state to an ordered one. After the formation of partially ordered (para-
crystalline) intermediates, the formation of a completely ordered assembly, 
named as critical nuclei, occurs59. Therefore, nucleation is the most difficult aim to 
reach both theoretically and experimentally. After nucleation, the next phase is 
the growth of the crystal, once a stable nucleus appears in a supersaturated 
solution. Supersaturation is a non-equilibrium condition where some molecules 
exceed the solubility limit and they are no more present in solution59. The 
equilibrium is then re-established by formation and development of a solid state 
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(i.e. the crystal) 59. To reach the supersaturation state, the properties of the 
undersaturated solution must be modified to reduce the ability of the medium to 
solubilize the protein or, on the contrary, some properties of the protein must be 
altered to reduce its solubility or / and to increase the attraction of the 
macromolecules by each other59. Under a practical point of view, it means to 
perturbate the relationship between solvent and solute in order to promote the 
formation of the solid state. All the components that allow the supersaturation 
state are named precipitants,which can be buffers that alter the pH, salts that alter 
the activity of the water or polymers that alter the interaction between protein 
and solvent. For this reason, the different combination of precipitants and their 
concentration are the key to force protein crystallisation59. For this purpose, 
different commercial kits for crystallisation screening are available, and this was 
the first approach to crystalize A075L. As the screening test is extensive, and many 
trials are required, the first goal is to obtain as much protein as possible. For this 
reason, an optimized purification method was set up, as described above in 
“expression and purification of recombinant A075L”. 
Then, the pre-crystallisation test described below, permitted to find the best 
concentration of both protein and buffer to obtain the correct protein 
precipitation avoiding amorphous formations. 
The x-ray diffraction is one of the most important techniques to study the 
macromolecules at the atomic level. By x-ray diffraction, it is possible to obtain the 
electronic density of a crystal when the x-rays diffract from it. When the waves hit 
the crystal, they can diffract in two different ways. With the constructive 
interference, they give rise to a diffraction pattern, but with the destructive one, 
they cancel by each other. The protein crystal is a sum of constructive and 
destructive interferences and, in the end, a diffraction pattern will give the 
information about the distributions and type of atoms that compose the crystal. 
Then, the diffraction pattern is mathematically interpretable as described by 






The first approach to set up the crystallography screening is the PCT test (pre 
crystallisation test) that allows to find the best conditions in terms of precipitants 
and protein concentration. 
The PCT kit (Hampton Research) contains 4 reagents used to evaluate protein 
concentration for crystallization screening. The protein concentration is evaluated 
with four solutions (A1, A2, B1, B2). If the sample is too concentrated itcan result 
in amorphous precipitate, while samples too diluted can result in clear drops. 
Optimizing protein concentration for the screening, is a key step in the 
crystallization process60. The PCT reagents contents are the following: A1 0.1 M 
Tris/HCl pH 8.5, 2.0 M (NH4)2SO4, B1 0.1 M Tris/HCl pH 8.5, 1.0 M (NH4)2SO4, A2 
0.1 M Tris/Hcl pH 8.5, 0.2 M MgCl2, 30% w/v Polyethylene glycol 4,000, B2 0.1 M 
Tris/HCl pH 8.5, 0.2 M MgCl2, 15% w/v Polyethylene glycol 4,00060. 
96 well plate screening 
According to the PCT results, 13 crystallization commercial screens for A075L were 
set up at 9mg/ml. in order to find the best one to have a crystal. Each plate 
contained 96 conditions and it was used  the so called “sitting drop” vapour 
diffusion at 18°C described by McPherson and Gaviria, J.A., 2013 59.  
 (NH4)2SO4 (Qiagen) JCSG+ (Molecular Dimensions) 
Salt Rx1-Rx2 (Hampton Research) Natrix (Hampton Research) 
Stura Macrosol (Molecular Dimensions) Pact (Molecular Dimensions) 
Midas (Molecular Dimensions) Proplex (Molecular Dimensions) 
Morpheus (Molecular Dimensions) Structure Screen (molecular Dimensions) 
Peg Ion (Hampton Research) Index (Hampton Research) 
NR-LBD (Molecular Dimensions)  
 





Each plate name is referred to the commercial kit used (from Molecular Dimension 
or Hampton research). Each kit differs in terms of precipitants, so using more kits 
for screening increases the probability to find the best nucleation condition.  As 
described previously in this chapter, A075L was derivatize with SeMet in order to 
derivatize the protein, as there are no models in literature to do a molecular 
replacement to solve the structure.At this point, SeMet A075L was used, after the 
PCT test, in a concentration of 9mg/ml and with UDP-Xyl in a ratio of 1:3 
protein:substrate. 
 
48 well plate screening 
After the first round of screening and the identification of the best crystallisation 
conditions, a new screening was started in order to improve the crystals.  
In particular, the best conditions were in: MIDAS A3: 45% polyacrylate 2100, 0.1 
M HEPES pH 6.5, MIDAS C10: 35% polyacrylate 2100, 0.2M NH4SO4, 0.1M HEPES 
pH 7.5, MORPHEUS A12: 0.06M Divalents (Mg2+ and Ca2+), buffer system 3 (0.1M 
TRIS-HCl-Bicine) pH 8.9, 37% MIX (MPD-Peg1K-Peg 3350). 
Three plates with 48 condition in each were set up, where each row (from well 1 
to 6) contained the same precipitant conditions, but different protein ratio (1:1, 
1:2, 2:1) repeated in double, and each column (from A to H) contained different 
concentration of the components (precipitant, buffer, salts…). 













Table 8. Midas A3 conditions. In this case rows from A to D contain HEPES buffer at pH 




For the X-ray diffraction analysis, crystals are removed from the drop and 
transferred for 1 minute into the same solution in which the crystal grew, 
supplemented with 20% glycerol for cryoprotection. Then, the crystal is flash 
frozen in liquid nitrogen and sent to the synchrotron. Several datasets were 
collected at Diamond Light Source (Didcot, UK) at beamline I04. The presence of 
the selenium was checked by the fluorescent scan around 12658 ev (see results 







2.1 A064R  
 
2.1.1 Sequence Analysis 
 
A064R is one of the six PBCV-1 putative glycosyltransferases and it is reported in 
the CAZY database as a GT-nc (glycosyltransferase not classified)18.  BLAST analysis 
on NCBI nr database using the full-length protein indicated that A064R is encoded 
by a subset of Chlorella viruses, which infect Chlorella variabilis and are closely 
related to PBCV-1. It is composed by 638 residues and at least three domains can 
be identified (Figure 25).  
The N-terminal domain (D1) has been already structurally characterized, 
confirming its inclusion among the  glycosyltransferases with  type A structural fold 
(GT-A) 57. Beside the subset of the Chloroviruses cited above, no significant match 
could be found in the viral world. Best identity with cellular organisms was found 
with some bacteria belonging to proteobacteria; sequence alignments among 
representative organism are depicted in Figure 26. Some highly conserved amino 
acids are found, corresponding to Gly 11, Asp78, Arg 202, Gly 196, and Phe 13, 
which are important for nucleotide-sugar substrate binding.  Also, the DXD motif 
typical for most GT-A type enzymes is present.  
The central region (D2) of the sequence did not match to any already recognized 
domain in the databases (Figure 24). BLAST analysis of the region 212- 410 
revealed that it displays significant identity with portions of multidomain putative 
proteins encoded by Pithovirus, Marseillevirus and Klosneuvirus. Best hits with a 
good query coverage for cellular organisms were found with some members of 
the Planctomycetales orders. Interestingly, sequences with about 50% identity are 
found in many Prevotella species. Thus, the identification of A064R second domain 
activity will help to elucidate also the function in these bacteria, which are very 
important components of the human intestinal, oral and also vaginal microbiota62. 
Figure 24 reports the sequence alignment of the second domain from some 
representative organisms. It is important to note that no specific feature for 
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known GT can be recognized, suggesting that this domain may represent a new GT 
fold.  
The last C-terminal domain (D3) was assigned to the S-adenosyl methionine 
dependent methyl transferase superfamily.  This superfamily comprises many 
families responsible for the transfer of a methyl group to different acceptor 
substrates. BLAST analysis gave significant hits with several putative class-I 


























Figure 25. A064R schematic representation. A064R conserved domains are highlighted. It 
is possible to note that no conserved domains are matched for D2. D1 is recognised as GT-
A domain, D3 as a methyltransferase domain. 
 
 
Figure 26. Sequence multiple alignment for D1. Conserved residues, involved in the 
substrate binding, are highlighted with a red row. DXD motif is highlighted in the red box.  
PBCV-1: AAK19297.1, Algoriphagus boseongensis: WP_133552711.1, Caballeronia 






Figure 27. Sequence multiple alignment for D2. D2 domain does not match with any 
conserved domain among organisms. Best hits are sequences belonging to NCLDVs, 
Planctomycetales and Prevotella species. 
PBCV-1: AAK19297.1, Pithovirus: QBK92091.1, Marseillevirus: QBK88047.1, Klosneuvirus: 






Figure 28. Sequence multiple alignment for D3. D3 domain matches with sequences form 
bacteria, identified as putative methyltransferases.  
PBCV-1: AAK19297.1, Verrucomicrobiales bacterium: MAD25665.1, Hyella patelloides: 




2.1.2 A064R Domain Expression  
 
On the basis of sequence alignments, A064R domains were produced as GST-
fusion proteins. Since alignments were not conclusively informative to define the 
exact boundaries of each domains, different forms were produced, in order to 
identify the minimum sequence required for activity. This problem resulted 
particularly important for the C-terminal end of the second domain, identified as 
D2.  
Initially, domain 1 (identified as D1, from amino acid 1 to 211, Table 9) and a 
shorter version of domain 2 (identified as D2 short, from amino acid 193 to 405, 
(table 7) were produced. A construct containing both domains was also prepared 
(D1+D2 short, from amino acid 1 to 405, table 7), in order to verify the reciprocal 
effects of the two regions on enzyme function. However, preliminary enzymatic 
tests revealed that D2 short protein was devoid of activity (see below, in the 
Enzymatic activity section) and that also for D1+D2 short protein only the N-
terminal domain had a GT activity. For this reason, we went back to analyse the 
second domain sequence with more detail. Carefully inspection of the PBCV-1 
variants revealed that CME6 mutant (Figure 23), which presents both L-rhamnose 
residues, but lacks methylation in the in Vp54 associated glycan51 , presents a TC 
dinucleotide insertion at genome position 36,276, which leads to premature chain 
termination during translation of domain 3 51. This finding prompted us to 
reconsider the C-terminal boundary of D2 and to produce an extended version at 
the C-terminus, containing 33 extra amino acids (D2 long, from amino acid 193 to 
amino acid 438, Table 9). 
 Accordingly, both domains were also produced comprising this C-terminal 
extension (D1+D2 long, from amino acid 1 to 438, Table 9).  Finally, the increasing 
availability of sequences in the databases to be used for sequence alignments 
suggested us to produce also a shorter version of domain 2, lacking the 17 amino 
acid from the N-terminal region, with the aim to identify the minimum length 




















       
 
Table 10. A064R domains SDS-PAGE. For each recombinant protein the GST-fusion 
protein (lane 1) and the soluble protein after protease cleavage (lane 2) are shown. 
A064R full length, A064R D1 and A064R D1D2 long displayed high solubility, indeed, they 
were the proteins with the higher enzymatic activity (see following paragraph). A064R 
D2 short, A064R D1D2 short, A064R D2L and A064R D2L2 were more difficult to obtain 





















638 1…638 74.9 75.8 150745 5.11 
A064R D1 211 1…201 25.5 51 54110 5.65 
A064R D1D2 
short 
400 1…400 47.5 74 123230 5.61 
A064R D1D2 
long 
438 1…438 51.8 77.7 127700 5.49 
A064R D2 
short 
212 193…405 25.15 51 70610 5.55 
A064R D2 
long 
245 193…438 28.9 54.8 73590 5.23 
A064R D2 
long 2 
231 207…438 27.2 53.4 73590 5.31 
 
Table 9. A064R domains.  The table displays the number of amino acids of each domain 
and the region that was cloned, the molecular weight (MW) with and without the tag used 
for the purification, and the parameters in terms of extinction coefficient and isoelectric 





All the recombinant proteins were produced using the same growth conditions 
and purified depending on the tag used (GST or 6xHis) (see experimental 
procedures section for more details). Table 10 displays the SDS-PAGE for each 
recombinant protein. 
A064R full-length, A064R D1, and A064R D1+D2 long are obtained as soluble 
recombinant proteins, with high enzymatic activity. In fact, as we demonstrate, D2 
needs 33 additional amino acids to be active and, in addition, need to be produced 
coupled with D1 in order to maintain the correct folding: D2 long 2, even if displays 






















2.1.3 A064R Domains Enzymatic Characterisation 
 
To test activity, the reactions were performed using the proteins after proteolytic 
cleavage from the GST or, as alternative, with the GST-fusion proteins still bound 
on the GSH-sepharose beads. This latter procedure facilitates the recovery of the 
supernatant containing the reaction product and it was also particular useful for 
NMR analysis. The samples were then analysed by HPLC and by NMR; this latter 
analysis was performed either directly to monitor the reaction or after HPLC 
purification of the products. 
A064R glycosyltransferase is supposed to act as a sequential UDP-L-rhamnosyl 
transferase; for this reason, the donor nucleotide-sugar substrate was synthesized 
in our laboratory, as described in the Material and Methods section. Conversely, 
the appropriate acceptor substrates were synthesized by Todd Lowarty laboratory 
at the University of Alberta, specifically octyl-β-xylose and the compound 
identified as Todd (Figure 29). Compounds Todd+1 and Todd+2 were expected to 
form by the sequential activity of D1 and D2 domains.  
 
 








Figure 30. Enzymatic activity proposed for D1 and D2. Both are UDP-rhamnosyl 
transferases. (a) D1 is able to transfer the UDP-L-rhamnose on the synthetic acceptor 
named as “Todd”, that displays the distal xylose. (b) At this point, D2 can attach the 









As described in the “Experimental procedure” section, each A064R form was 
tested for the enzymatic activity in the presence of the appropriate substrates. 
Bivalent cations were also added or omitted; EDTA was also used, to chelate 
residual ions that remained bound to the proteins during the purification 
procedures, in order to confirm the effect of cation presence. The reactions were 
verified by HPLC at T0 and at different incubation times. After HPLC purification, 
the product was also analysed by NMR, in Prof. De Castro laboratory, to confirm 
its structure, and in particular the linkage type and configuration.  
As expected, A064R D1 was able to transfer the first UDP-rhamnose to the 
acceptor substrate “Todd” forming the compound named Todd+1 (Figure 31), 
according to the scheme in Figure 30, panel (a)). This reaction was performed in 
the presence of the bivalent cation Mn2+ (Figure 31, panel (a)). When Mn2+ was 
omitted and also EDTA was added to chelate the residual ions, no activity could be 
observed, indicating the need of bivalent cations for activity, as also reported for 
most GTs (Figure 31, panel (b)). Figure 31, panel (c) reports the NMR analysis of 
Todd+1 product; the first rhamnose residue is linked to xylose by a β1,4-glycosydic 
bond, as demonstrated for the Vp54 associated glycan, thus demonstrating that 









Figure 31. (a) A064R D1 enzymatic activity. As the HPLC chromatogram shows, the 
conversion of the substrate is completed after 4h with the addition of one rhamnose to 
the free xylose exposed by the synthetic acceptor Todd. (b) In addition, the incubation 
in presence of EDTA demonstrates that the enzyme needs cations to be active. (c) The 
NMR spectra of the purified product demonstrate that A064R D1 is a retaining 




Figure 32. A064R D2 enzymatic activity. No product formation was detectable also 





On the contrary, it was not possible to demonstrate any activity for A064R D2 
short domain, also in the presence of bivalent cations (either Mg2+ or Mn2+) (Figure 
32). To verify if D2 necessitates of D1 to acquire a correct folding and the catalytic 
activity, we also produced the two domains together (D1+D2 short). However, 
while it was possible to verify D1 activity, with the formation of Todd+1, D2 short 
did not show again any catalytic activity (data not shown).  
As already indicated in the previous section, D1 and D2 were then produced 
together, but D2 was elongated with 33 amino acid at the C-terminus (D1+D2 
long). This protein finally showed the two expected activities: the first responsible 
for the attachment of the first β1,4-linked rhamnose by D1 domain and then 
elongation of the first rhamnose with the second α1,2-linked rhamnose residue, 
catalysed by D2 domain, with the formation of Todd+2 compound (Figure 33). 
Interestingly, the bifunctional protein was able to use also octyl-xylose as 
substrate, indicating that the complex glycan moiety is not required for substrate 
recognition, but the xylose residue is the only determinant for recognition by D2 
active site. This finding is particularly interesting, since it opens perspective for the 






Figure 33. A064R D1D2 long enzymatic activity. (a) The reactions are carried out 
in the presence of “Todd”, that displays only xylose; (b) reaction with “Todd+1” 
acceptor, which displays the first rhamnose. (c) octyl-xylose was used as 
alternative acceptor substrate; conversion to the product was completed after 
2h (red line). (d) NMR analysis after the product purification of reaction (c) 
















In order to define the minimum sequence needed for enzymatic activity of the 
second domain, two other forms of A064R D2 were produced: A064R D2 long, 
which comprise amino acid 193 to 438, and D2 long2, which is 17 amino acid 
shorter at the N-terminus, but which has the C-terminal extension (see Table 9 
and enzymatic reaction in Figure 34). Comparable activity and cation 
independence were also observed for D2 long2 protein; this indicated that the first 
17 amino acids at the N-terminus of D2 long are not essential for protein structure 
and activity (Figure 34). 
 
 
Figure 34. A064R D2 long and A064R D2 Long 2 long enzymatic reactions. As is possible 









Enzymatic tests also revealed that D2 long does not need the addition of bivalent 
cations for activity. In fact, when EDTA was added to the reaction mixture, D2L 
maintained full activity (Figure 35). 
 
Figure 35. A064R D2L enzymatic reaction in the presence of EDTA. The panel (a) clearly 
demonstrate that the enzyme, in the presence of EDTA, is still active. The “Todd + 2” 




The cation independent activity of the second domain poses questions about its 
catalytic mechanism.  Since D2 cannot be assigned to any known GT family, neither 
GT-A (which are cation-dependent), nor GT-B (which could be cation 
independent), it is possible that D2 represents a new, not yet recognized, type of 
GT fold. 
D3 was not as yet produced as isolated domain; however, the possibility to 
produce the full-length protein allowed to test also its proposed 





Figure 36. Enzymatic activity proposed for D3. D3 is supposed to methylate the distal L-







Indeed, upon incubation of the full length protein with the nucleotide sugar donor, 
UDP-L-rha, the methyl donor SAM and octyl-Xyl as acceptor, it was possible to see  
a new specie during HPLC analysis, with a retention time higher compared to the 
specie with the two Rha residues (Figure 37). However, NMR analysis revealed the 
presence of only the methyl on C2 position of the distal L-rhamnose thus indicating 
that another methyltransferase, which still needs to be identified, may be 
responsible for the addition of the 3-O-methyl group, as demonstrated by NMR 
analysis. Figure 38 recapitulates also the NMR spectra of the different products 
obtained using the A064R domains and full-length protein. 
 
 
Figure 37. A064R full length enzymatic reaction. Using the full-length protein, D1, D2 and 
D3 activities are tested. After the overnight incubation, it is possible to appreciate the 








Figure 38. Products obtained by A064R domains and full-length protein analysed by NMR. 
As it is confirmed by NMR, A064R D1 catalyses the transfer of the proximal L-rhamnose 







2.2.1 Sequence Analysis 
 
A075L is a 280 amino acid protein and it represents the second putative PBCV-1 
GT studied so far. It is supposed to be a putative UDP-xylosyltransferase, thanks 
to its conservation among Chloroviruses2 . Database searches cluster it in the 
exostosin family, as a GT-32 member. In other organisms exostosin proteins are 
responsible for the synthesis of heparan sulphate. In mammals three exostosins 
have been identified, named as EXT1, EXT2, EXT3, and they are ER resident 
glycosyltransferases63 . The heparan sulphate repeating units do not display xylose 
as sugar, but they are composed by the disaccharide formed by D‐glucuronic acid 
and N‐acetylglucosamine molecules linked by β‐ (1–4) and β‐ (1–3) glycosidic 
bonds.  
Orthologs with high identity with A075L were found in most members of the 
Choroviridae infecting Chlorella variabilis and Chlorella heliozoae, confirming a key 
role of this protein in the formation of the glycan core structure. Sequences 
annotated as exostosin were also found in other members of the NCLDVs group. 
Specifically, A075L displayed a 37% identity (E-value 7e-47) with a region of a 
multidomain protein from Heterosigma akashiwo virus 1 and about 30% with 
Pheocystis globosa virus and some other members of the Mimiviridae family. 
Morevoer, conserved orthologs were identified in cellular organisms, with 
identities of about 30%. Alignment of A075L with representative sequences 








Figure 39. A075L sequence multiple alignment. A075L is well conserved among NCLDVs 







Figure 40. A075L multiple alignment among cellular organisms. A075L displays about 30% 
of identity with some bacteria and eukaryotes. The conserved domain is identified as 
exostosin domain that is a type of GT domain.  
PBCV-1: NP_048423.1, Terrimicrobium sacchariphilum: WP_075077865.1, 





2.2.2 A075L Expression 
 
A075L purification protocol was optimized in order to obtain higher amount of 
protein to ensure enough quantity for the ITC experiments, the NMR experiments 
and crystallization screening. In this way, it was possible to perform all tests using 
the same batch of protein. Figure 41, box 1 reports the results from the initial 
purification steps using GSH-sepharose affinity resin and the release of A075L 
soluble protein from GST by proteolytic cleavage. After these initial purification 
steps, it was possible to obtain a quite large amount of A075L with minimal GST 
contamination (Figure 41 box 1, lane 12). However, to ensure highest purity, the 
protein obtained after the last GSH-sepharose purification step was subjected to 
a further anion exchange purification: a main peak was observed, followed by a 
shoulder (Figure 41, Box 2, upper panel). All fractions were then analysed by SDS-
PAGE (Figure 41, Box 2, lower panel). Fractions from A8 to B11, corresponding to 
the main peak were pooled together, concentrated to 15.5 mg/ml in 1ml, split in 
50 µl aliquots, flash frozen in liquid nitrogen and stored at -80°C. The final yield 
was of 3,75 mg of protein par 1L of growth in LB. Fractions from B10 to B4 were 
considered as possible aggregate forms of the protein and appeared more 
contaminated by other species (Figure 41, Box 2, lower panel), so they were 
discarded.   
A similar protocol was used to purify the recombinant protein produced with Se-
Met (Figure 42). In this case three peaks were observed (Figure 42, box 2 upper 
panel). Only the first main peak, corresponding to fractions A1 to A12 (Figure 42, 









BOX 1. WT A075L purification, GSH elution, Overnight cleavage 
 1. Soluble protein fraction 
2. Insoluble protein fraction 
3. Proteins not adsorbed on the resin 
beads 
4. Resin beads before elution  
5. Wash fraction 
6. Resin beads after elution  
7. Elution with PBS 20 mM GSH 
8. Prescission protease cleavage ON 
9. Resin after GST binding 1  
10. Flow through after binding 1 
11. Resin after GST binding 2 (2 ul) 
12. FT after binding 2 
13. Prescission protease control 
BOX 2. WT A075L anion exchange purification 
 















Figure 41  A075L purification. Box 1 displays all the purification steps verified by SDS PAGE. 
BOX 2 reports the anion exchange purification and the SDS-PAGE of the chromatographic 
fractions. Fractions A8 to B11 corresponding to “peak 1” were pooled together and 






BOX 1. SeMet A075L purification, GSH elution, Overnight cleavage 
 1. Soluble protein fraction 
2. Insoluble protein fraction 
3. Proteins not adsorbed on the resin beads 
4. Resin beads before elution  
5. Wash fraction 
6. Resin beads after elution  
7. Elution with PBS 20 mM GSH 
8. Prescission protease  cleavage ON 
9. Resin after GST binding 1  
10. Flow through after binding 1 
11. Resin after GST binding 2 (2 ul) 
12. FT after binding 2 
13. Prescission protease control 















Figure 42.  SeMet A075L purification. Box 1 displays all the purification steps verified by 
SDS PAGE. BOX 2 displays the anion exchange purification and the positive fractions 
verified by SDS PAGE. Fractions A9 to A12 corresponding to “peak 1” were pooled 
together and concentrated. 
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2.2.3 A075L Characterisation  
Isotermal Titration Calorimetry (ITC) 
ITC was used to address the dissociation constant (Kd) of A075L with UPD-xylose. 
The thermodynamic parameters are shown in Figure 43 and Figure 44. The results 
show similar Kd of A075L for UDP-xylose in presence of Mg2+ (28.7 µM) or Mn2+ 
(23.3 µM). The stoichiometry (N = 0.5) means that one molecule of UDP-xylose 
could bind to two molecules of A075L, i.e. one UDP-xylose bound to a dimer of the 




Figure 43. ITC of A075L vs. UDP-xylose in presence of MgCl2. The top graph 
represents the differential heat released during the titration of 1 mM UDP-
xylose into 100 µM A075L. The bottom graph represents the fitted binding 
isotherms. Thermodynamic parameters of A075L interaction with UDP-xylose in 






Figure 44. ITC of A075L vs UDP-xylose in presence of MnCl2. The top graph 
represents the differential heat released during the titration of 1 mM UDP-
xylose into 100uM A075L. The bottom graph represents the fitted binding 
isotherms. Thermodynamic parameters of A075L interaction with UDP-xylose in 














Nuclear Magnetic Resonance (NMR) 
 
NMR experiments were performed in order to confirm the binding of A075L to 
UDP-xylose. UDP-xylose was incubated with the purified A075L protein directly in 
the NMR tube and the reaction was monitored with time.  
Results shown in Figure 45 indicate that a progressive hydrolysis occurs, with a 
formation of free xylose. Upon addition of the enzyme to UDP-xylose, the quick 
formation of β-xylose could be appreciated in NMR spectrum, in the red trace, 
corresponding to time 0, is indicated by an asterisk. Peak height increased at 15 
minutes, with the concomitant appearance of the α anomeric specie (green trace, 
Figure 45). The initial formation of the β-anomer could suggest an inverting 
reaction mechanism, as it can be expected for the xylosyltransferase activity which 
use UDP-α-xylose as donor.  
Since the hydrolysis reaction proceeded quite slowly, it was also tested in the 
presence of ions (Mg2+ or Mn2+), but a significant increase of the reaction speed 
was not appreciable for both ions also at long incubation time (Figure 46). 
According to this information, the enzyme probably needs to bind also the 
acceptor substrate to promote the reaction. The effects of bivalent ions still 






Figure 45. A075L is an inverting glycosyltransferase. The results show that A075L 
hydrolyzes UDP-α-xylose possibly with an inversion of the anomeric configuration of the 
xylose. Although βXyl is the major anomer in equilibrium for free xylose (Approx 70:30), 








Figure 46. A075L and UDP-xylose in the presence of divalent ions. Panel (a) shows the 
reaction in the presence of Mn 2+. because of Mn 2+ is paramagnetic, the reaction is 
difficult to follow, because of the background. Panel (b) shows the reaction in the 





Enzymatic reaction of A075L 
As the ITC and NMR experiments demonstrate, A075L binds UDP-xylose; however, 
the hydrolysis reaction was slow, indicating the need of the acceptor to promote 
the enzymatic activity. Thus, enzymatic tests were set up to demonstrate its 
catalytic activity. 
Free fucose and octyl-fucose were initially used as acceptor substrates, in the 
presence of bivalent cations; indeed, previous experiments with A064R D1 domain 
showed that the presence of a complex oligosaccharide structure was not 
necessary to promote the enzymatic activity. Reactions were monitored by NMR, 
but no product formation was observed. This finding suggested the enzymes 
requires a more complex structure, i.e the core region of Vp54-associated glycan, 
for recognition as substrate. Presently this structure needs to be chemically 
synthetized, or as alternative, a glycopeptide displaying the truncated glycan could 
be purified from E11 or E1L3 mutants (see Figure 23 in introduction section) as 
described by Speciale et al 51. 
Indeed, preliminary results were obtained using a small amount of the purified 
E11 glycopeptide incubated with UDP-xylose and  they showed that A075L is able 
to transfer the xylose unit to the acceptor, thus definitively confirming its 
enzymatic activity and indicating that a more complex glycan structure is needed 
for recognition of the acceptor substrate by the enzyme active site (Figure 47). 
Unfortunately, the amount of the glycopeptide that can be purified from E11 
mutant is very low, due to virus instability and poor recovery after the end of the 
infectious cycle. For this reason, a more detailed enzymatic characterization was 







Figure 47. A075L enzymatic reaction. A075L was incubated overnight in the presence of 
the acceptor, directly purified from de mutant variant E11, and with both cations Mg2+ 
and Mn2+. This preliminary data, coupled with the demonstration that A075L is able to 





















2.2.4 A075L Structural Characterization 
 
Crystallization procedure 
After protein purification and concentration, the pre crystallization test (PCT test) 
was set up to find the best condition for crystallization in terms of salts, polymers 
and protein concentration. In fact, samples too concentrated can result in 
amorphous precipitate, while samples too diluted can result in clear drops. 
Precipitate and clear drops are typical crystallization results during screening, due 
to reagent conditions that do not promote crystallization and are formed in every 
crystallization screen. However, by optimizing protein concentration, it is possible 
to enhance chances for crystallization. For this reason, PCT can minimize or 
prevent situations where a screen results in an overabundance of precipitate or 
clear drops 60. According to the PCT test results, the best concentration of protein 
was around 9 mg/ml.  
This first screening is necessary to validate as much combinations as possible, in 
order to identify the ones where the protein concentration and the solution 
components can create the best condition to allow protein crystallization. In fact, 
each well contains different conditions of salts, pH, buffer and polymers, all of 
them defined as precipitants. For the screening, 13 plates (prepared using WT 
A075L and SeMet A075L) with 96 different condition in each were set up, using 
the available commercial kits. After a week some nucleation was observed. 
According to this result, a further screening with 48 wells plates was started. The 
48 well plates allowed also to use higher amounts of protein, in order to obtain 
bigger crystals. 
First screening was performed using the underivatized A075L protein (WT A075L), 
in order to find the best conditions. Finally, after identification of the best 
conditions,  A075L was labelled with Selenomethionine(SeMet A075L), since no 
crystallographic structures of homologs proteins are available for molecular 
replacement64.  
Figure 48 shows the MALDI-TOF analysis of SeMet A075L, which shows an increase 
of molecular weight of the protein from 33.597 to 33.806. That indicates the 
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incorporation of 5 residues of SeMet (149.21), as expected for the sequence of the 




Figure 48. SeMet A075L MALDI-TOF spectrum. SeMet A075L was analysed by mass 
spectrometry in order to confirm the presence of selenomethionine. As the WT protein 
molecular weight is around 33,5 kDa, it can be assumed that the increase of the 
molecular weight is due to SeMet incorporation. 
 
 





The conditions that allowed the formation of the best crystals were the ones in 
the Morpheus screening (see Table 6. Morpheus A12 condition. This 48 well plate 
displayed a lot of crystals that were removed from the drop and flash frozen in 
liquid nitrogen, then stored as described in experimental procedure section, in 
order to be sent for the X-ray diffraction. One SelMet A075L dataset diffracted at 
3.1 Å and the space group was determined to be P1, phasing of the structure is 
still in progress.  
Figure 50 depicts a representative drop of crystals used for X-ray analysis and the 
corresponding data collection statistics. The data processing for determining the 




Figure 50. SeMet A075L Crystals and data collection statistics. SeMet A075L crystal was 





The interest in giant viruses has grown over the past 30 years, from Acantamoeba 
mimivirus1 discovery  in 1992 by Timothy Robotham, a microbiologist at Leeds 
Public Health Laboratory. Since then, the research in this topic has expanded very 
fast and many information obtained by scientist all over the world are available. 
First, it is now well established that giant viruses are widely diffused in the 
environment, infecting eukaryotic organisms such as plants, algae and animals. 
Especially, metagenomic studies in the oceans have established that giant viruses 
are probably the most represented viruses after bacteriophages in the sea water, 
influencing directly or indirectly many biogeochemical and ecological processes, 
including biodiversity and genetic transfer, CO2 fixation and carbonate sinking, 
nutrient cycling and algal bloom control7,48. Secondly, according to phylogenetic 
studies, it has been also demonstrated that they share a common ancestry65, 
which classifies them in a monophyletic group, indicated as Nucleo-Cytoplasmic 
Large DNA Viruses (NCLDVs). At the same time, genes from bacterial, archaeal or 
eukaryotic origins are commonly found in the same virus, suggesting also that 
extensive horizontal gene transfer occurs. At this purpose, viruses could represent 
a kind of “melting pot” for different genomes26. 
The main characteristic that has emerged from the studies on giant viruses is the 
huge particle dimension, which is necessary to contain the large genome. In fact, 
they possess a double stranded DNA genome ranging from 0.3 to up to 1.2 Mbp, 
this being a size comparable to that observed for cellular organisms. Additionally, 
genome analysis of sequenced viruses has revealed the presence of genes that are 
not usually found in viruses, but that are typical of eukaryotic organisms and are 
able to confer partial independence from the cell host. Indeed, it was 
demonstrated that they possess the replication machinery, proteases, part of the 
translation system, enzymes involved in redox reactions and the enzymes involved 
in glycosylation and modification of glycans 39.  NCLDVs also encode for a large set 
of genes exclusively found in this kind of viruses, which functions are presently 
unknown. For instance, of the 900 putative genes of Mimivirus, only 25% of them 
have a homologue in databases7. 
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As NCLDVs are cellular parasites, but that maintain partial independence from the 
host mechanisms, a new definition of “virus” is going to be defined. As suggested 
by Forterre and colleagues, the question “are viruses alive?” probably will need a 
new answer24. To date, viruses were always considered not alive organisms, which 
depend totally from the infected hosts. Now, there are on the contrary evidences 
and demonstration that giant viruses display uncommon characteristics for a virus, 
giving them the new definition as “giruses”, comprising the information of big 
dimension (giant) in term of viral particle and large genome1, and proposing, more 
recently,  the new  order of “Megavirales”, as suggested by Claverie et al.44 
In the present work, we characterized two glycosyltransferases identified in 
Paramecium Bursaria Chlorella virus-1 genome. Previous PBCV-1 genome analyses 
suggested the presence of an autonomous glycosylation system in this virus. This 
hypothesis was confirmed by the characterisation of the glycan structure exposed 
by the main capsid glycoprotein Vp-54. In fact, the glycoforms identified and 
solved by De Castro et al50 show some peculiarities that presently pose them as 
unique in all kingdom of life, specifically the β-Glc linked to Asn, which is not found 
in the typical consensus sequence for N-linked glycosylation, and finally the 
complexity of the glycan structure.  Thus, solving of the glycoform structure has 
confirmed that PBCV-1 encode for its own glycosyltransferases. At least 6 
(A111/114R, A546L, A075L, A064R, A071R A219/222/226R, A473L) have been 
identified.  
A064R is encoded only by PBCV-1 and few closely related Chloroviruses and it is 
not found in any other NCLDVs39. Discovery of PBCV-1 spontaneous glycosylation 
mutants provided important information to understand how the glycoforms are 
synthetized. The mutants analysed, in fact, showed Vp-54-associated aberrant 
glycoforms and most mutations were found in A064R gene51, further indicating its 
glycosyltransferase activity. The reduced stability of the virus and the lower yield 
of the mutant viral particles observed after the end of the infection also suggested 
an important role for A064R in virus life cycle51. 
A064R is a multidomain enzyme and, thanks to the spontaneous mutant studied 
and thanks to database search, we identified in the protein two 
glycosyltransferases domains (D1 and D2) and one methyltransferase domain 
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(D3). As this work demonstrates, D1 and D2 are rhamnosyltransferases that attach 
the two distal rhamnose of the glycoform, confirming the bioinformatic analysis. 
D3, as a putative methyltransferase, is identified thanks to the identification of a 
mutant that lacks on the methyl groups on the last distal rhamnose, coupled with 
a mutation in the D3 gene region. Preliminary experiments using the full length 
protein have confirmed D3 enzymatic activity, but deeper characterization is still 
undergoing51. 
It is important to note that often the giant virus glycogenes are clustered in 
multidomain enzymes that ensure a metabolic channeling of substrates. For 
A064R, the three enzymatic activity are sequentially arranged, and the second 
domain is able to transfer the nucleotide-sugar on the acceptor only after the 
addition of the previous sugar by the first domain. This mechanism is particularly 
important to increase the rate of glycan formation in the viral factories and it 
represents a parallel to what happens in cellular organisms. Indeed, in particular 
in eukaryotes the sequential and coordinated activity of the GTs is ensured by the 
fact that they are mostly membrane bound and they are localized in specific area 
of the secretory pathway, where they can also form hetero oligomers. Other 
examples for a multidomain GT in PBCV-1 is represented by A111/114, which is 
currently under study.  
A second interesting feature of the rhamnosyltransferase is the broad acceptor 
specificity. In fact, D1 is able to catalyse the addition of the proximal L-Rha to the 
simple xylose monosaccharide or to a lipid linked xylose, indicating that the 
complex core glycan is not essential for recognition. Moreover, also D2 attaches 
the second L-rha to first one, without needing a more complex olisaccharide for 
interaction with the active site. This open perspective for the use of these two 
domains, which are soluble and produced in good amounts, also for 
glycotechnological application. Further studies are needed to better understand 
their substrate specificity and catalytic properties.  
Particularly interesting is A064R D2 domain. In fact, it does not match with any 
already identified domain in database search in any superkindoms of life, 
suggesting that it may represent a new GT fold. It is also a retaining, cation 
independent, GT. Since homologous sequences are present in several bacterial 
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species, in particular in Prevotella, the characterization of this new GT type will 
open the way to identify new still unknown glycogenes.   
The second enzyme that has been characterised in this work is A075L. A075L is not 
exclusive of PBCV-1, but it is present among most Chloroviruses, a subfamily of 
Phycodnaviruses where PBCV-1 is the viral model2. A075L was indicated as the 
UDP-xylosiltransferase, responsible of the transfer of the distal xylose on the core 
fucose, but it does not have significant homology with other xylosyltransferases 
already characterized in the literature. However, the bioinformatic analysis assigns 
it an exostosin domain, that is a inverting GT involved in heparan sulphate 
synthesys in both prokaryots and eukaryots18. This finding is quite surprising since 
exostosins are processive enzymes, which lead to the formation of long 
polysaccharide chains and are supposed to remain bound to the glycan substrate 
during monosaccharide addition.  
Both NMR and ITC experiments on A075L demonstrated that the enzyme binds 
the substrate UDP-xylose. Incubation of the enzyme alone with the nucleotide 
sugar donor in the absence of the acceptor causes hydrolysis, which seems to 
proceed following an inverting mechanism. In addition, the Kd from the ITC 
analysis suggested that one molecule of UDP-xylose can bind two molecules of the 
protein, suggesting that the enzyme works as a dimer. However, no informations 
are currently available on A075L quaternary structure. Since a good diffraction 
spectrum was obtained from the last X-ray crystallography experiments, A075L 
structure is going to be solved and this will provide an explanation about this 
finding.  
Testing the enzymatic activity of A075L proved to be more complicated, compared 
to A064R. In fact, while A064R first domain displayed a broader substrate 
specificity, with rhamnose monosaccharide being the only determinant for 
recognition by the active site, A075L did not show any catalytic activity on free 
fucose or lipid -immobilized fucose. Conversely, it was able to transfer a xylose 
unit on the E11 mutant glycan, which has the completely formed core structure 
and lack just the distal xylose moiety, thus demonstrating the proposed activity. 
The very low availability of the mutant glycan prevented the possibility to go on in 
the enzymatic characterization. However, chemical synthesis of glycan acceptors 
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is currently underway in the laboratory of Todd Lowarty at the University of 
Alberta and it will provide important information about the minimum glycan 
composition required for recognition by A075L active site. 
In conclusion, the results obtained in this work contribute to shed light on the 
complex glycosylation machinery of giant viruses, in particular of Chloroviruses. 
Evidences obtained so fare clearly indicate that the viral glycosylation machinery 
is unusual and different from the ones found in cellular organisms, but how it was 
established and evolved is not clear.  Many important pieces are still missing to 
draw the complete picture: for instance it is still debated if glycan formation occurs 
by a sequential step-by–step elongation of the glycan already bound to the 
protein, as it happens for O-linked glycosylation in Eukaryotes, or if a complete 
glycan is formed on a lipid linked precursor and it is then transferred “en-bloc” to 
the protein, with a mechanism similar to the N-linked formation in both 
Eukaryotes and Bacteria. 
For Chlorovirus no information is known about the enzyme responsible for the 
attachment of the β-glucose to the Asn lateral chain. This type of linkage is very 
uncommon and very few enzymes have been identified to be able to catalyse this 
reaction in Bacteria and Archaea50. However, no homologs for these sequences 
were identified in PBCV-1 and other Chlorovirus genomes. So, the search for this 
possible protein-N-glycosyltransferase is still ongoing. Thus, several questions are 
still open about the formation of viral glycoproteins, including the mechanisms for 
glycan production and their subcellular localization, and about the origin of the 
viral enzymes and their relationships with those from cellular organisms. The 
identification of the viral enzymes involved in these pathways represents the 
starting point to clarify all these issues7. 
The presence of a complex and partially well conserved glycosylation machinery 
in Chlorovirus suggest that surface glycans are highly important at some point of 
the virus replicative cycle. Indeed, the spontaneous mutants that show aberrant 
glycoforms identified so far have a strongly reduced virulence. The heavily 
glycosylated surface can in fact provide protection against the external 
environment, as it is seen for bacterial capsular material and for some types of 
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spores7. Moreover, the glycan presence can also help capsid protein folding and 
promote the stability of the viral particle.  
The study of the giant virus glycosylation pathways is important since it can 
increase our understanding about their life cycle and evolution. Moreover, the 
viral glycogenes, and in particular their glycosyltransferases, could also have 
interesting biotechnological application. GT are used to date to synthetized 
glycosides of pharmaceutical and industrial interest: glycosylated molecules (such 
as antibodies or polysaccharides) are used as drugs for many pathologies, from 
cancer to vaccines4,23. Usually, the synthesis of new drugs is limited from the fact 
that GTs are really specific, and sometimes a variation in the glycan decoration is 
needed to modify the pharmacokinetic/pharmacodynamics of glycosides. At this 
point, protein engineering is applied in order to modify the specify of GTs for 
glycan substrates and acceptors.  
The identification of new family of GTs, such as A064R D2 that belongs to a new 
class mechanism, could be of special interest. Moreover, D1 domain of A064R does 
not have a strict requirement of a complex glycan as acceptor and it could for 
instance useful for the in vitro production of rhamnolipids. Indeed, these 
compounds are presently of great interests for several applications, but, since they 
are mainly purified by Bacteria, such as Pseudomonas, their biomedical use is 
often prevented by the possible carryover of contaminants.     
Other polysaccharides are directly purified from target organisms and can be 
difficult to obtain for the copurification of impurities or in term of yield and, as 
additional problem, the direct chemical synthesis could be tricky22.  As the viral 
GTs displays high solubility and high production yield in E. coli, the possibility to 





4. Future perspectives 
 
As it is largely described in the discussion section, the discover and the study of 
new classes of GTs have an important biotechnological interest. At this purpose, 
the understanding of the new enzymatic mechanism identified for A064R D2 is the 
next step that need to be investigated. A064R D2 does not match with any already 
identified domain in the databases, suggesting that it could represent a new GT 
fold: starting from this observation, the NCLDVs glycogenome might be analysed 
in order to identify similar domains or, on the contrary, putative viral GTs that does 
not have any matches could be investigated to explore new GTs mechanisms. 
According to that, the full comprehension of PBCV-1 glyco system should be 
pursued. As it is described in the previous pages, there are still some PBCV-1 
putative GTs that are not characterized yet, such as the multidomain enzyme 
A111/114R. The characterisation of these enzymes and the resolution of the GT 
domain structure, will be then helpful to classify new domains that are not 
identified yet in the viral glycogenome, not only in Chloroviruses, but all over the 
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